Body Systems

Brain

Other NamesBean

Natural Remedies10

Ingredients343

Table of contents

Other Names

BeanBrainstemCerebellumCerebrumDiencephalonEncephalonForebrainGray matterGrey matterHindbrainMedulla oblongataMesencephalonMetencephalonMidbrainMyelencephalonNogginNoodlePateProsencephalonRhombencephalonTelencephalonUpper story

Synopsis

Brain

Overview and Definition

The human brain is perhaps the most complex biological system, with the mature brain composed of more than 100 billion information-processing cells called neurons. It is an organ of nervous tissue that commands task-evoked responses, movement, senses, emotions, language, communication, thinking, and memory. The brain connects to the spinal cord, and together they make up the central nervous system (CNS). An adult human brain weighs, on average, about 3 pounds; at birth it weighs about 1 pound and grows to about 2 pounds through childhood.

Human brain development starts with the neurulation process from the ectodermic layer of the embryo and takes, on average, 20 to 25 years to mature. It occurs sequentially and in an organized manner, beginning with the neural tube formation at the third or fourth week of gestation. This is followed by cell migration and proliferation that leads to the folding of the cerebral cortex to increase its size and surface area, creating a more complex structure.

Major Structural Components

The Cerebrum

The cerebrum is the largest part of the brain, divided into the right and left hemispheres. Its surface contains folds and convolutions, with the ridges between the convolutions called gyri and the valleys between the gyri called sulci (plural of sulcus). If the sulci are deep, they are called fissures. The preponderance of the cerebral cortex, which with its supporting structures makes up approximately 80 percent of the brain's total volume, is actually a recent development in the course of evolution. The cortex contains the physical structures responsible for most of what we call "brainwork": cognition, mental imagery, the highly sophisticated processing of visual information, and the ability to produce and understand language.

The folds in the brain add to its surface area and therefore increase the amount of gray matter and the volume of information that can be processed. Each cerebral hemisphere can be divided into sections, or lobes, each of which specializes in different functions.

Frontal Lobe: The two frontal lobes lie directly behind the forehead. When you plan a schedule, imagine the future, or use reasoned arguments, these two lobes do much of the work. One of the ways the frontal lobes seem to do these things is by acting as short-term storage sites, allowing one idea to be kept in mind while other ideas are considered. The frontal lobe is the largest of the lobes and the most complex part of the brain. It controls executive functions, a set of cognitive processes that are necessary to manage behavior and meet goals, such as time management, organizational skills, and the ability to switch focus.
Parietal Lobe: Beyond the cortex's role in cognition and language, underlying specialized structures are essential for movement, consciousness, sexuality, the action of the five senses, and more.
Occipital Lobe: The fourth and final lobe of the cerebrum is the occipital lobe, which is the smallest lobe of the cerebrum and forms the caudal part of the brain. The primary function of the occipital lobe is the interpretation of visual information.
Temporal Lobe: The limbic system includes the amygdala, which processes emotions, and the hippocampus in the temporal lobe — which is like a "memory indexer" that sends memories to certain parts of the brain for storage, and retrieves them when needed.

The two hemispheres are connected mainly by a thick bundle of nerve fibers called the corpus callosum, or "hard body." A smaller bundle, the anterior commissure, connects just the two temporal lobes. The bilateral arrangement allows for some flexibility if one hemisphere is injured; often the other hemisphere can compensate to some degree, depending on the age at which injury occurs.

Gray Matter and White Matter

There are two tissues in the brain known as gray and white matter. Gray matter is the darker, outside section (the cerebral cortex) that helps with day-to-day functioning, including muscle control, using the senses, remembering, experiencing emotions, and speech. White matter is the lighter section below the gray matter that sends signals to different parts of the central nervous system to help with function. The interplay between the gray matter of the cortex and the white matter of subcortical fibers is critical for efficient communication within the brain, facilitating higher-order functions such as learning, memory, and executive control.

Neurons and Glial Cells

There are close to 86 billion nerve cells (neurons) in the human brain and an equal amount of non-neuronal glial cells. Neurons send and receive electric and chemical signals. Glial cells help maintain the brain, form myelin (a fatty, protective substance found in white matter), and provide nutrition to the brain. All neurons share four common regions: the cell body, dendrites, axon, and axon terminal. The cell body of the neuron has a nucleus responsible for the synthesis of proteins that travel through microtubules down to the axons and axon terminals.

Microglia are phagocytic cells representing the immune and support system of the CNS and are the most abundant cells of the choroid plexus. Oligodendrocytes, present only in the CNS, are responsible for the production of myelin, which maintains the electrical impulse conduction of nerve signals and maximizes their velocity as needed.

The Cerebellum

Upon reception of motor information from both the cerebral cortex and the musculoskeletal structures of the body, the cerebellum coordinates these signals to maintain gait and posture in motion. Although the cerebellum itself does not initiate muscle contraction, it aids in the refinement and accuracy of motor activity by controlling muscle tone. In addition to its role in controlling balance and regulating motor movement, the cerebellum also plays a role in the regulation of fear and other cognitive functions such as attention, language, and the human response to pleasure.

The Brainstem

The brainstem is at the base of the brain and connects the cerebrum and the spinal cord. It includes three parts: the midbrain, the medulla oblongata, and the pons. The midbrain is a highly complex structure with many neuron clusters, pathways, and other structures; it is primarily involved in motor functions (particularly eye movement) and audio and visual processing. The medulla oblongata is at the bottom of the brainstem, where the brain and spinal cord meet; it is crucial for the most basic survival functions like heart rate, breathing, blood flow, and oxygen levels. The pons is the connector between the midbrain and the medulla oblongata. It is where four of the 12 cranial nerves originate, enabling a wide range of activities, including tear production, chewing, blinking, balance, and facial expressions.

The Limbic System

The limbic system is a grouping of cortical and subcortical structures involved in memory formation and emotional responses. It allows for complex interactions between the cortex, thalamus, hypothalamus, and brainstem. It is not defined by strict anatomic boundaries but incorporates several important structures, including conventionally the amygdala, hippocampus, fornix, mammillary bodies, cingulate gyrus, and parahippocampal gyrus.

The Thalamus and Hypothalamus

The thalamus, in the center of the brain, relays sensory and motor information to the cortex and helps with consciousness, sleep, and alertness. The hypothalamus, about the size of a pearl, directs a multitude of important functions. It wakes the body up in the morning and gets adrenaline flowing during stress. The hypothalamus is also an important emotional center, controlling the chemicals that make a person feel exhilarated, angry, or unhappy. The hypothalamus is situated deep inside the center of the brain and links the nervous system to the endocrine system by producing and releasing hormones.

The Ventricles and Cerebrospinal Fluid

The original hollow structure of the embryonic neural tube is commemorated in the form of the ventricles, which are cavities containing cerebrospinal fluid. During development, the three bulges become four ventricles: in the hindbrain is the fourth ventricle, continuous with the central canal of the spinal cord; a cavity in the forebrain becomes the third ventricle, which leads further forward into the two lateral ventricles, one in each cerebral hemisphere.

Physiological Functions

Sensory Processing and Motor Control

The brain's job is to send, receive, and process signals through the central nervous system. These signals carry information from the five senses — sight, smell, sound, touch, and taste. The brain also identifies signals from inside the body, such as pain, temperature, and heart rate. It interprets and translates this information so a person can understand and associate meaning with what goes on around them.

Energy Metabolism

Glucose is the primary energy source responsible for maintaining brain metabolism and function. Neurons use the most significant amount of glucose to process information. The brain requires a continuous supply of glucose as it has limited glucose reserves. CNS symptoms and signs of hypoglycemia include focal neurological deficits, confusion, stupor, seizure, cognitive impairment, or death.

Higher Cognitive Functions

The brain works precisely, making connections, and is a deeply divided structure that has not been entirely explained or examined. Although researchers have made significant progress in experimental techniques, the human cognitive function that emerges from neuronal structure and dynamics is not entirely understood.

Neuroendocrine Integration

The secretion of melatonin by the pineal gland varies significantly over a 24-hour cycle, from low levels during the day to a peak at night; the pineal gland has been called a "third eye" because it is controlled by neurons sensitive to light that originate in the retina. In animals with a clear-cut breeding season, the pineal gland is a link between shifting hours of daylight and the hormonal responses of the hypothalamus. In humans, there is evidence that melatonin has a share in regulating ovulation.

Assessment of Brain Health

Brain health assessment subtests are designed to efficiently evaluate key cognitive domains that can be affected in neurocognitive disorders. Performance is summarized across domains, and the most affected domain also separately contributes to the determination of impairment, so that patients with a significant but circumscribed impairment are not missed. An informant survey elicits key symptoms for diagnosis, including socioemotional changes and level of functional impairment.

Most cognitive screens emphasize the detection of memory dysfunction, a hallmark of Alzheimer's disease, but neglect other domains such as visuospatial or executive functions. An estimated 40–50% of dementias are caused by non-Alzheimer's diseases, most commonly Lewy body disease, frontotemporal lobar degeneration, and vascular disease, which frequently present with non-memory symptoms.

Standard Clinical Tools

Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA): Historically, paper-and-pencil assessment tools such as the MMSE and the MoCA have been the most common methods for evaluating cognitive function. However, recent digital innovation has ushered in significant advancements in cognitive testing.
Neuropsychological Test Batteries: The Trails B test is an established neuropsychological test that evaluates cognitive flexibility, attention, visual scanning, and memory by assessing ability to switch between numbers and letters while connecting circles in ascending order.
Imaging and Electrophysiology: Neuroimaging and electrophysiological techniques have enhanced understanding of the thalamus's integrative role in sensory perception and cognitive processing and its potential involvement in neurologic disorders. Disruptions in thalamic function may contribute to conditions such as schizophrenia, attention-deficit hyperactivity disorder, and Alzheimer's disease.

Multidimensional Brain Health Indices

Multidimensional assessment approaches such as the BrainHealth Index include composite scores and empirically derived subdomain scores measuring Clarity (cognitive health), Connectedness (social health), and Emotional Balance (mental health). These include validated measures sensitive to change, including gains or losses associated with behavior change and integration of cognitive strategies into daily life.

Factors Supporting Normal Brain Function

Authoritative evidence identifies several lifestyle and physiological factors as supportive of normal brain function. Micronutrients encompassing both vitamins and trace elements play a central role in brain development, metabolic homeostasis, and cognitive performance from early life through old age. Many of these nutrients influence transcriptional programs, shape synaptic signaling, and participate in neuroimmune and neuroendocrine crosstalk; observational, interventional, and experimental studies show that both deficiency and excess of specific micronutrients are linked to changes in memory, mood, attention, and executive function.

Nutrients Studied to Support the Brain

Omega-3 Polyunsaturated Fatty Acids (EPA, DHA, ALA)

Scientific Evidence

Omega-3 is a polyunsaturated fatty acid (PUFA) that has an essential impact on cognitive performance at all stages of life. Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA) are essential for brain functions. DHA, the dominant omega-3 in the brain, impacts neurotransmitters and functions of the brain.

A systematic review collating evidence from 25 randomized controlled trials (n = 3,633) published since 2013 found that, compared with control groups, omega-3 supplementation generally correlated with improvements in blood biomarkers. Meta-analytical evidence from clinical trials and observational studies showed that more than 1 g/day DHA/EPA significantly improved episodic memory in older adults with a history of mild memory complaints.

Dietary supplementation with omega-3 fatty acids may influence brain function by altering membrane fluidity, the activity of membrane-bound enzymes, ion channel function, receptor affinity and number, and signal transduction pathways that regulate neurotransmitter and neuronal growth factor activity. Epidemiological research has suggested an association between a low omega-3 fatty acid intake and an increased risk of cognitive decline or dementia, particularly Alzheimer's disease.

However, evidence in established Alzheimer's disease is limited. A recent systematic meta-analysis did not show any significant benefits of omega-3 fatty acid supplementation in the treatment of mild to moderate Alzheimer's disease, even if the treatment did not raise any substantial safety issues. Omega-3 fatty acid supplementation in mild Alzheimer's disease may be beneficial at disease onset, when there is slight impairment of brain function. Although some studies have shown changes in scales of cognitive function in more severe cases, they are not enough to support omega-3 fatty acid supplementation in the treatment of established Alzheimer's disease. Overall, the evidence base is mixed and dependent on population, dose, and disease stage.

B Vitamins (Folate, B6, B12)

Scientific Evidence

B vitamins may exert their effect on the brain directly through their acute influence on hypomethylation, and indirectly through their long-term influence on homocysteine levels.

A systematic review investigated the efficacy of B vitamins, antioxidant vitamins, and vitamin D on the cognitive function of non-demented middle-aged or older people, using randomized or quasi-randomized controlled trials of individuals aged 40 years or older. Twenty-three studies on B vitamins (comprising folate, B6, and B12) were included. Taking B vitamins for over 3 months was beneficial for global cognition (standardized mean difference −0.18, 95% CI −0.30 to −0.06) and episodic memory (SMD −0.09, 95% CI −0.15 to −0.04). The effect sizes observed were modest and the authors noted the need for further investigation into optimal supplementation duration.

Vitamin D

Scientific Evidence

Increasing evidence suggests that neuronal effects of vitamin D should be considered an essential contributor to the development of cognition in early years and its maintenance during aging. The developmental disabilities induced by vitamin D deficiency include neurological disorders such as attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia, characterized by cognitive dysfunction. On the other hand, vitamin D deficiency has frequently been associated with dementia of aging and neurodegenerative diseases, including Alzheimer's and Parkinson's disease.

Various cells within the central nervous system — including neurons, astrocytes, and microglia — express vitamin D receptors, and some are capable of synthesizing and catabolizing the active form of vitamin D via specific enzymatic pathways. However, clinical trial results on vitamin D supplementation's cognitive benefits are inconclusive. Vitamin D's neuroprotective effects are complex, influencing cognitive abilities by interacting with neuronal and glial cells, modulating immune responses, and regulating key molecular pathways. Challenges remain in clinical applications, including determining optimal vitamin D levels, effective supplementation forms and doses, and identifying responsive populations.

Observational studies link low vitamin D levels to increased cognitive deterioration risk, particularly in Alzheimer's disease, vascular dementia, Parkinson's disease, and schizophrenia. The overall evidence is preliminary; well-designed interventional trials are still needed.

Choline

Scientific Evidence

Key vitamins including choline contribute to brain function by influencing transcriptional programs, shaping synaptic signaling, and participating in neuroimmune and neuroendocrine crosstalk. Nutrients such as choline and vitamin D have been evaluated for their efficacy on cognitive functioning in more recent research. Choline is a precursor to the neurotransmitter acetylcholine, which is central to learning and memory; however, robust large-scale interventional trials demonstrating direct cognitive benefit from choline supplementation in healthy individuals remain limited.

Herbs and Natural Ingredients Studied to Support the Brain

Ginkgo biloba

Traditional Use

Ginkgo biloba has a multi-century history of use in a variety of age-associated impairments and has long been touted as a potential treatment or preventive for loss of memory and thinking function in late life. Ginkgo biloba is a large tree with a distinctive fan-shaped leaf and a long history of use in traditional Chinese medicine.

Scientific Evidence

Ginkgo biloba is thought to be beneficial to human health as a neuroprotective agent, antioxidant, free-radical scavenger, membrane stabilizer, and inhibitor of platelet-activating factor (through terpene ginkgolide B).

The Ginkgo Evaluation of Memory (GEM) Study is the most definitive clinical trial to date. This was a randomized, double-blind, placebo-controlled clinical trial conducted in 5 academic medical centers in the United States between 2000 and 2008. More than 3,000 people age 75 or older with normal cognitive function or mild cognitive impairment were randomly assigned to take a ginkgo supplement or a placebo for a median of 6 years. There was no difference between the ginkgo and placebo groups in the rates at which participants developed dementia of any type or Alzheimer's disease.

The rate of total dementia did not differ between participants assigned to ginkgo versus placebo (3.3 per 100 person-years vs. 2.9 per 100 person-years; HR, 1.12; 95% CI, 0.94–1.33; P = 0.21), and the rate of Alzheimer-type dementia also did not differ between the two treatment groups.

Despite the GEM findings, smaller and shorter studies have suggested possible benefit in symptomatic dementia populations. In a systematic review of 15 clinical trials, in eleven studies ginkgo extract/EGb 761® was shown to improve cognitive function, neuropsychiatric symptoms, and functional abilities in both dementia types, while in four studies there were no significant differences between the ginkgo-treated and placebo groups. Significant improvements were observed in scores from the Mini-Mental State Examination, Short Cognitive Performance Test, and Neuropsychiatric Inventory.

The NCCIH summarizes: there is no conclusive evidence that ginkgo biloba is efficacious in preventing or slowing dementia or cognitive decline. The large placebo-controlled randomized clinical trial found it ineffective in lowering the overall incidence of dementia and Alzheimer's disease. Further analysis of the same data also found ginkgo to be ineffective in slowing cognitive decline, lowering blood pressure, or reducing the incidence of hypertension. Ginkgo extract may have a modest benefit for dementia symptoms, particularly at relatively high doses, but the evidence is inconsistent. It is unclear whether ginkgo is helpful for symptoms of milder cognitive impairment.

Bacopa monnieri (Brahmi)

Traditional Use

Bacopa is an herbal extract made from the fresh or dried leaves of Bacopa monnieri, a creeping, herbaceous plant native to the Indian subcontinent that has been used for centuries in Ayurvedic medicine to treat anxiety, depression, memory loss, and epilepsy. This medicinal Ayurvedic herb is traditionally used for various ailments, but is best known as a neural tonic and memory enhancer. In classical Ayurvedic texts, it is referred to as a "medhya rasayana" — a class of herbs used specifically to promote intellect and memory.

Scientific Evidence

Bacopa monnieri leaves and roots have more than 100 components including flavonoids, flavones, saponins, triterpenoids, glycosides, sterols, and lipids. The active ingredients are thought to be saponin glycosides referred to as bacosides.

Current evidence suggests Bacopa monnieri acts via the following mechanisms: anti-oxidant neuroprotection via redox and enzyme induction, acetylcholinesterase inhibition and/or choline acetyltransferase activation, β-amyloid reduction, increased cerebral blood flow, and neurotransmitter modulation (acetylcholine, serotonin, dopamine).

At least six high-quality randomized, double-blind, placebo-controlled human trials have been conducted. A systematic review found some evidence that "Bacopa could potentially be clinically prescribed as a memory enhancer" even in non-demented subjects. Bacopa monnieri administration significantly improved 9 out of 17 free recall memory tasks; however, Bacopa showed no improvement in memory involving the recall of short passages of text.

Verbal learning, memory acquisition, and delayed recall according to the AVLT significantly improved in the Bacopa monnieri group compared to placebo at 12 weeks, while the other assessments showed minor improvements that did not differ significantly between the two groups.

Twenty-two identified clinical trials demonstrated that Bacopa monnieri can reduce Nuclear Factor-κB phosphorylation, improve emotional function, cognitive functions, anhedonia, hyperactivity, sleep routine, depression, attention deficit, learning problems, memory retention, impulsivity, and psychiatric problems.

Preclinical and early clinical data suggest benefit, but larger, longer studies are needed to confirm this. Laboratory studies have identified possible mechanisms of action for broad neuroprotection in brain aging, and some early clinical trials suggest that Bacopa is somewhat nootropic. Well-designed human clinical trials comparing Brahmi with conventional agents are few and need to be replicated in wider study groups. One key limitation is the considerable variability in the composition of Bacopa monnieri extracts.

Lion's Mane Mushroom (Hericium erinaceus)

Traditional Use

Lion's mane is extensively found in East Asian countries including Japan and China. The mature mushroom is easily identifiable, consisting of a number of single, long, dangling fleshy spines which are white in colour. H. erinaceus has traditionally been used as a herbal medicine in East Asian countries with well-documented health-promoting effects.

Scientific Evidence

Lion's mane is a medicinal, edible mushroom that contains many compounds, namely hericenones and erinacines. Cognitive effects with lion's mane have been mixed based on small and short-duration clinical trials. Preclinical studies suggest that lion's mane may be able to increase levels of a molecule called nerve growth factor (NGF), which increases the length of nerve cell processes.

Although much of the current research on H. erinaceus is based on animal and in vitro studies, several clinical trials have explored its potential benefits in humans, particularly in neurodegenerative diseases, cognitive function, and gastrointestinal health. One of the most significant clinical trials investigated the effects of H. erinaceus supplementation on cognitive function in 50- to 80-year-old Japanese men and women with mild cognitive impairment. In a randomized, double-blind, placebo-controlled study, subjects who consumed H. erinaceus extract for 16 weeks showed significant improvements in cognitive performance compared to the placebo group.

Reductions in cognitive decline were also observed in patients diagnosed with mild Alzheimer's disease following 49-week supplementation with erinacine A-enriched H. erinaceus. This trial observed improvements on the Mini-Mental State Examination at week 49, alongside significant treatment-related differences in Instrumental Activities of Daily Living scores, suggesting better cognition and a lower level of dependence following supplementation.

However, a more recent acute crossover study in healthy young adults found more limited effects: the results showed no significant effect of H. erinaceus fruiting body extract for composite measures of global cognitive function and mood. When analysing individual tests, participants exhibited improved performance on the pegboard test at 90 minutes following a single dose. In conclusion, acute consumption did not demonstrate a significant overall improvement in cognitive performance and mood compared to placebo, and any benefits may be task or domain specific.

Clinical trials testing lion's mane interventions have included small numbers of participants with short durations of treatment. Well-designed larger and longer clinical trials are needed. Overall, the evidence is preliminary and encouraging but not yet conclusive.

Other Studied Nutrients and Phytonutrients

A comprehensive narrative review of human clinical trials summarized 96 articles across 21 categories of nutrients and phytonutrients studied for cognitive function, including α-lipoic acid, B vitamins, cholinergic precursors, vitamin D, vitamin E, ginkgo biloba, ginseng, lion's mane mushroom, N-acetyl cysteine, omega-3 fatty acids, aloe polysaccharides, Rhodiola rosea, rosemary, saffron, tart cherries, turmeric, wild yam, Withania somnifera, xanthines, and zinc. Noteworthy effects on cognition that were assessed included memory, recollection, attention, intelligence, vocabulary, recognition, response inhibition, arousal, performance enhancement, planning, creative thinking, reaction time, vigilance, task switching, orientation to time and place, reading, writing, comprehension, accuracy, learning, information processing speed, executive function, mental flexibility, daily functioning, decrease in mental fatigue, and freedom from distractibility. The evidence for individual agents in this broader category varies widely from preliminary animal data to small clinical trials, and most require further investigation in larger human populations.

Conditions and Diseases of the Brain

Some 100 million Americans suffer from devastating brain disorders at some point in their lives. The NINDS supports research on more than 600 neurological diseases. Neurological disorders pose a large burden on worldwide health. The neurological disorders included in the Global Burden of Disease Study — Alzheimer's and other dementias, Parkinson's disease, multiple sclerosis, epilepsy, and headache disorders — represent 3 percent of the worldwide burden of disease. Dementia, epilepsy, migraine, and stroke rank in the top 50 causes of disability-adjusted life years (DALYs).

Alzheimer's Disease and Other Dementias

Alzheimer's disease is a high-burden disease with an increasing prevalence as the population ages. It is a clinically complex, age-related neurodegenerative disorder with significant pathological brain changes and no curative treatment. Current therapeutic approaches primarily alleviate symptoms rather than halt disease progression. An estimated 40–50% of dementias are caused by non-Alzheimer's diseases, most commonly Lewy body disease, frontotemporal lobar degeneration, and vascular disease, which frequently present with non-memory symptoms.

Parkinson's Disease

Dementia and Parkinson's disease are among the top 15 conditions with the most substantial increase in burden in the past decade. Vitamin D deficiency has frequently been associated with Parkinson's disease and other neurodegenerative conditions.

Epilepsy

Epilepsy ranks in the top 50 causes of disability-adjusted life years globally, and represents approximately one-quarter of the total neurological disease burden.

Migraine and Headache Disorders

Migraine, tension-type headache, and medication-overuse headache are included among the major contributors to the worldwide neurological burden of disease. Migraine represents approximately one-third of this total neurological burden.

Multiple Sclerosis

Advances in understanding the nervous system are beginning to pay off in the form of treatments for previously untreatable disorders and conditions such as spinal cord injury, acute stroke, multiple sclerosis, epilepsy, and Parkinson's disease.

Rare Neurological Disorders

Of an estimated 7,000 known rare diseases that lead to significant morbidity and mortality in 25 million people in the United States, a third are thought to include a neurological component. Examples of rare neurological conditions studied by NIH-funded scientists include amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, and Huntington's disease.

Cognitive Impairment and Mild Cognitive Impairment (MCI)

Even Alzheimer's disease can present with dysfunction in visuospatial, executive, or language domains rather than memory. Cognitive screens typically rely on a single, global cut-off score to determine if a patient is impaired, which may fail to detect circumscribed, non-memory deficiencies. Signs and symptoms of brain conditions vary and could affect mental health, movement, memory, thinking, and speech, among other important functions.

Disruptions in Thalamic Function

Disruptions in thalamic function may contribute to conditions such as schizophrenia, attention-deficit hyperactivity disorder, and Alzheimer's disease.

References

Natural Remedies

Remedy 1

Omega-3-Rich Fatty Fish: Salmon, sardines, and mackerel are packed with DHA, an omega-3 fatty acid critical for brain cell structure and repair. Aim to eat two or more servings per week; DHA has been linked to improved cognitive function, slowed cognitive decline, and increased blood flow to the brain.

Remedy 2

Blueberries Daily: Blueberries are rich in flavonoid antioxidants that improve signaling in brain pathways and protect neurons from oxidative stress. Add a half-cup of fresh or frozen blueberries to oatmeal, yogurt, or smoothies each day to support memory and learning.

Remedy 3

Turmeric (Curcumin) with Black Pepper: Turmeric's active compound, curcumin, has anti-inflammatory and antioxidant properties that support brain health. Stir half a teaspoon of turmeric into warm milk, soups, or cooking daily — pairing it with black pepper significantly increases curcumin's absorption.

Remedy 4

Ginkgo Biloba Tea or Extract: Ginkgo biloba has been used for centuries to improve cognitive function and memory; it contains flavonoids and terpenoids that protect the brain from oxidative stress and improve cerebral blood flow. Use a standardized extract or brew dried leaves as a tea once daily, following label guidance.

Remedy 5

Bacopa Monnieri (Brahmi): Used in Ayurvedic medicine for centuries, Bacopa contains bacosides that support nerve cell growth, improve neurotransmitter function, and protect against oxidative stress. Take as a tea or standardized supplement consistently for several weeks, as its memory-enhancing effects build gradually over time.

Remedy 6

Lion's Mane Mushroom: Lion's Mane is a medicinal mushroom whose bioactive compounds — hericenones and erinacines — stimulate nerve growth factor (NGF) production, promoting the growth of new brain cells and protecting against age-related cognitive decline. Add powdered Lion's Mane to coffee, broth, or smoothies, or take it as a capsule supplement daily.

Remedy 7

Leafy Greens & Rosemary: Dark leafy greens such as spinach and kale provide folate and antioxidants that protect against cognitive decline; rosemary is a traditional herb long associated with memory support. Include a large daily serving of leafy greens in meals, and cook with fresh or dried rosemary regularly to harness both dietary and aromatic benefits.

Remedy 8

Prioritized Sleep Hygiene: Deep sleep is when the brain's glymphatic system flushes toxic proteins linked to cognitive decline, and adults need 7–9 hours nightly for optimal brain health. Establish a consistent bedtime and wake time, keep the bedroom cool and dark, avoid caffeine after mid-afternoon, and reduce screen exposure in the evening to protect natural melatonin production.

Remedy 9

Regular Aerobic Exercise: Aerobic activities such as brisk walking, running, swimming, or cycling trigger the release of brain-derived neurotrophic factor (BDNF), which stimulates the growth of new neurons, increases gray matter volume, and improves memory and executive function. Aim for at least three sessions of 30–40 minutes per week at a moderate intensity for meaningful cognitive benefit.

Remedy 10

Mindfulness Meditation & Stress Reduction: Chronic stress elevates cortisol, which can damage the hippocampus and impair memory over time; regular mindfulness or meditation practice trains attention and reduces stress-driven neurological damage. Practice 10–20 minutes of focused breathing or guided meditation daily — even short, consistent sessions help build cognitive resilience and emotional regulation.

Ingredients

These ingredients are often used in alternative medicine to support brain.

2'-fucosyllactoseScientific
Preclinical studies provide substantial evidence that 2'-FL exerts direct and gut-microbiome-mediated neuroprotective effects. In rodent stroke models, 2'-FL reduced brain infarction, suppressed microglial activation, and upregulated BDNF. In a transgenic Alzheimer's disease mouse model (5xFAD), 2'-FL improved cognitive performance, reduced amyloid-beta plaque deposition, and attenuated neuroinflammation and oxidative stress. 2'-FL also promotes neurodevelopment in weaning mouse models by altering gut microbiota and increasing expression of neuronal markers NeuN and myelin basic protein. No human clinical trials for brain outcomes have been published.
5-HTP (5-hydroxytryptophan)Scientific
5-HTP is the direct precursor to serotonin (5-HT), a key neurotransmitter regulating mood, cognition, appetite, and sleep. A 2025 RCT in older Singaporean adults (100 mg/day for 12 weeks) found significant increases in MoCA cognitive scores and serum serotonin in the 5-HTP group. It crosses the blood-brain barrier, unlike serotonin itself, making it an effective serotonin-boosting agent.
abies spectabilisScientific
Preclinical in vivo studies have confirmed antianxiety, antidepressant, anticonvulsant, sedative, and antistress activities in A. spectabilis—all reflecting CNS/brain-directed pharmacological effects. These are listed in peer-reviewed pharmacological reviews as confirmed in vivo bioactivities.
acetyl-L-carnitineScientific
Acetyl-L-Carnitine (ALC) has been studied across multiple randomized controlled trials for cognitive decline, mild cognitive impairment, and dementia. A 2003 meta-analysis of 21 double-blind, placebo-controlled trials showed a statistically significant advantage for ALC over placebo in cognitive improvement (pooled effect size 0.201). Mechanisms include restoring synaptic function, enhancing cholinergic activity, and supporting mitochondrial energy metabolism.
acetyl-L-tyrosineScientific
N-Acetyl-L-Tyrosine is a more bioavailable acetylated form of L-tyrosine, a precursor to the catecholamine neurotransmitters dopamine and norepinephrine. It has been studied for supporting cognitive performance under conditions of stress, fatigue, and sleep deprivation. Clinical research suggests tyrosine supplementation can mitigate working memory decline under acute stress.
adzuki beanScientific
Adzuki bean extract inhibits amyloid-β42 aggregation and delays cognitive decline in Alzheimer's Drosophila models. Animal studies show adzuki bean reverses HFD-induced memory impairment. Adzuki bean phenolics demonstrate acetylcholinesterase inhibitory activity relevant to neurochemical pathways in cognitive decline.
AKG (alpha-ketoglutarate)Scientific
Animal and cell evidence shows Ca-AKG improves cognitive function, reduces brain oxidative damage, and rescues synaptic plasticity in Alzheimer's mouse models. AKG's age-related decline (~10-fold by age 80) is hypothesized to contribute to brain aging. The ongoing ABLE RCT includes cognitive outcomes as secondary endpoints. Human brain-specific trial data are not yet published.
akkermansia muciniphilaScientific
A. muciniphila influences brain function through gut-brain axis metabolites including SCFAs (propionate, acetate), GABA modulation, and neuroinflammation suppression. In animal models it prevented cognitive impairment, reduced hippocampal synaptic loss, mitigated Alzheimer's-related amyloid pathology, and reversed high-fat diet-induced hippocampal neuroinflammation. Human evidence is limited to microbiome-association studies for neurodegenerative and psychiatric conditions.
ALA (alpha-linolenic acid)Scientific
ALA is a key component and protective agent for brain health, supporting cognitive function, synaptic plasticity, and protection against neurodegeneration. It upregulates BDNF, reduces neuroinflammation, and protects against Alzheimer's-related amyloid toxicity.
ALA (alpha-lipoic acid)Scientific
ALA crosses the blood-brain barrier and functions as a neuroprotective agent by scavenging reactive oxygen species, reducing neuroinflammation, protecting the blood-brain barrier, and supporting mitochondrial energy production in neurons. Clinical evidence includes RCTs showing ALA reduces postoperative cognitive dysfunction and brain injury markers in surgical patients.
algal oilScientific
DHA is the dominant structural fatty acid in the brain, essential for neuronal membrane fluidity, synaptic plasticity, and neurotransmitter function. The MIDAS trial demonstrated direct cognitive benefits of 900 mg algal DHA/day in healthy older adults. Algal DHA also reduces brain aging biomarkers including amyloid-beta and oxidative damage markers in preclinical models.
almondScientific
Clinical and preclinical evidence supports almond consumption benefiting brain health through antioxidant protection (vitamin E), support of neurotransmitter function (acetylcholine elevation in animal studies), and improvements in specific memory and spatial cognitive domains in a human RCT. Emerging evidence also connects almond-derived gut microbiome changes to brain function via the gut-brain axis.
alpha-glycosyl isoquercitrinScientific
Two preclinical studies (2023, 2024) demonstrated AGIQ improves learning/memory and alleviates depression-like behavior in mice via the gut microbiota–blood–brain axis, increasing hippocampal taurine and serotonin (5-HT). The MDPI 2022 review classifies AGIQ as neuroprotective. No human neurological RCTs have been published.
alpinia galangalScientific
A. galanga's neuroprotective and psychostimulant effects on the brain are supported by human RCTs (improved alertness, focus, attention) and preclinical data (AChE inhibition, antioxidant neuroprotection, anti-neuroinflammation). A dedicated PMC neuroprotective review covers CNS disease-relevant evidence.
amberScientific
Amber extract has demonstrated neuroprotective effects in human dopaminergic brain cells in vitro, reducing apoptosis via ROS and ERK pathway modulation and autophagy. TCM also documents amber for brain-related conditions including memory, seizures, and mental agitation.
anchoviesScientific
DHA accounts for approximately 10–20% of all fatty acids in the brain's gray matter and is the dominant structural lipid of neuronal membranes. Anchovies are a primary dietary source of DHA and EPA. Clinical evidence links higher omega-3 intake to improved memory, lower Alzheimer's risk biomarkers, and reduced depression and cognitive decline.
anemarrhena asphodeloidesScientific
Brain-related effects of anemarrhena are among its most studied attributes: AChE/BuChE inhibition, hippocampal acetylcholine augmentation, BACE1 inhibition, anti-neuroinflammation, and improvement of learning and memory deficits in multiple dementia models. The rhizome is specifically classified in TCM as a brain function-improving herb.
appleScientific
Apple polyphenols, particularly quercetin, have neuroprotective properties with relevance to the brain. Epidemiological data associate apple/flavonoid intake with reduced cognitive decline. Quercetin reduces neuroinflammation, crosses the blood-brain barrier, and has shown memory-improving effects in animal models of Alzheimer's disease.
aronia melanocarpaScientific
Aronia melanocarpa anthocyanins cross the blood-brain barrier and have been shown in human RCTs to improve cognitive performance, psychomotor speed, and serum BDNF levels. Animal studies demonstrate attenuation of memory impairment, reduced brain tissue damage, and upregulation of neuroprotective proteins (BDNF, p-CREB) in the hippocampus.
ashitabaScientific
Ashitaba compounds protect against brain demyelination and raise BDNF in mouse models. DMC (from ashitaba) reduces protein aggregates in Drosophila brains via autophagy. NGF-enhancing coumarins from ashitaba roots support neuronal survival. No human brain studies exist.
ashwagandhaScientific
Ashwagandha (Withania somnifera) is an Ayurvedic adaptogen with multiple RCTs demonstrating improvements in cognitive performance, working memory, stress, and anxiety. A double-blind crossover study (2022, n=59) showed that 225 mg liposomal ashwagandha extract improved word recall, recognition, and reaction time in healthy young adults. The active withanolides appear to modulate stress-related neurochemistry and support cholinergic function.
aspartic acidScientific
D-aspartic acid is an endogenous amino acid found in human brain tissue (fetal and adult) and CSF, localized particularly in the frontal cortex and hippocampus. It acts as a neuromodulator via NMDA receptors, influencing synaptic plasticity and neuroendocrine signaling. Its temporal abundance in fetal brain suggests a role in neural development.
astaxanthinScientific
Astaxanthin crosses the blood-brain barrier and has documented neuroprotective effects in human trials. RCTs in healthy middle-aged and older adults show improvements in memory, processing speed, and mood at 6–12 mg/day. A 2025 Frontiers review confirmed modulation of synaptic plasticity and neurogenesis pathways. Evidence for disease-modifying effects in neurodegenerative conditions remains preclinical.
aster rootScientific
Preclinical studies show Aster root extract suppresses neuroinflammation in astrocyte cell models, mitigates amyloid-β aggregation in transgenic mouse models, and modulates hippocampal cholinergic and anti-apoptotic pathways. These findings support potential relevance to brain inflammatory conditions and cognitive function, though all evidence is preclinical.
astragalusScientific
Astragalus polysaccharides, AS-IV, and cycloastragenol protect the brain through neuroprotection, BDNF upregulation, anti-neuroinflammation, and telomerase activation. A double-blind RCT in middle-aged adults showed improved cognitive metrics with an astragalus-based telomerase activator over 6 months. Preclinical evidence shows inhibition of Alzheimer's disease hallmarks.
bacillus coagulansScientific
Multiple RCTs document B. coagulans' effects on brain-relevant endpoints including depression rating scales, anxiety scores, and neurotransmitter levels (GABA, serotonin, dopamine). These effects are mediated through the gut microbiota-brain axis. Clinical RCTs show improvements in HAM-D, MADRS, HAMA, and CGI scores.
bacopaScientific
Bacopa monnieri (brahmi) is among the most studied herbal nootropics. Multiple meta-analyses and systematic reviews encompassing RCTs confirm small but significant improvements in memory recall, attention, and cognitive processing speed, primarily attributed to bacosides A and B. A systematic review of 9 double-blind, placebo-controlled trials found 8 demonstrated improvements in memory, attention, cognition, and mood.
bacopinScientific
Bacopin is a proprietary standardized extract of Bacopa monnieri, standardized to bacoside content. Clinical studies using standardized Bacopa extracts at 300 mg/day have consistently demonstrated memory-enhancing and cognitive-processing benefits in both healthy adults and elderly populations, attributable to its bacoside content improving synaptic transmission and antioxidant defense in hippocampal tissue.
bacosideScientific
Bacosides are the primary bioactive saponin compounds in Bacopa monnieri responsible for cognitive-enhancing effects. They modulate synaptic transmission, increase hippocampal neuronal density, inhibit acetylcholinesterase, and upregulate antioxidant defenses. Multiple RCTs using Bacopa standardized to bacosides confirm memory-recall and cognitive-processing improvements at 300 mg/day.
baikal skullcapScientific
S. baicalensis flavonoids cross the blood-brain barrier and exert direct neuroprotective, anti-neuroinflammatory, and neurotransmitter-modulatory effects in the brain, with evidence spanning Alzheimer's, Parkinson's, epilepsy, ischemia, and cognition/mood research.
bananaScientific
Banana provides tryptophan, vitamin B6, magnesium, and carbohydrates that support brain serotonin synthesis, neurotransmitter balance, and cognitive function. Epidemiologic data link banana consumption to depressive symptom scores, and RCT-level evidence exists for B6-mediated anxiolytic effects. Banana bioactive compounds including phenolics and neuromodulatory amines have neuromodulatory activity.
barberryScientific
Berberine from barberry has preclinical evidence for neuroprotective effects in the brain, including reduction of amyloid plaques, neuroinflammation, and oxidative stress. Gut-microbiome-brain axis modulation, AMPK activation in neural tissue, and antidepressant-relevant mechanisms are documented.
barrenwortScientific
Icariin is extensively studied as a neuroprotective agent in animal models of Alzheimer's disease, brain ischemia, depression, and aging. It reduces amyloid-beta and tau pathology, upregulates BDNF/TrkB signaling, activates Nrf2 antioxidant pathways in neural tissue, and has radioprotective neurogenic effects. All evidence is currently from preclinical research.
basilScientific
Clinical RCTs document cognitive improvements (memory, attention, reaction time) with holy basil. Preclinical evidence shows basil polyphenols stimulate BDNF/NGF, protect hippocampal neurons from oxidative stress, and prevent neurodegeneration. Cortisol-lowering in stressed adults has been demonstrated in a powered RCT.
beetScientific
Beetroot nitrate-derived NO increases cerebral blood flow, particularly to the frontal cortex. Some RCTs show acute improvements in cognitive performance and executive function. Evidence for sustained cognitive benefits in older adults is mixed, with some trials showing no effect over 13 weeks.
benfotiamineScientific
Benfotiamine targets brain-specific pathology including impaired glucose metabolism, AGE-driven neurodegeneration, microglial neuroinflammation, and thiamine-dependent enzyme deficits. A phase IIa RCT in MCI/mild AD showed significant improvements on CDR and FDG-PET brain metabolism. Preclinical studies confirm amelioration of amyloid and tau pathology, with a large national Phase 2B trial ongoing.
berberineScientific
Berberine exerts neuroprotective effects in preclinical brain disease models—reducing amyloid-beta, tau pathology, and neuroinflammation—and modulates neurotransmitter systems. It crosses the blood-brain barrier in animal studies. Indirect human evidence comes from metabolic risk reduction and a clinical IBS-depression RCT; direct human brain endpoint trials are absent.
beta and delta tocopherolsScientific
Post-mortem brain analysis found that gamma-tocopherol (coexisting with delta in the diet) concentrations correlate inversely with Alzheimer's disease amyloid burden and neurofibrillary tangles. Dietary intake of all tocopherol forms including beta and delta was associated with lower Alzheimer's disease incidence in the Chicago Health and Aging Project. Non-alpha tocopherols scavenge reactive nitrogen species that damage neuronal proteins and DNA, a mechanism alpha-tocopherol cannot replicate.
beta-alanineScientific
Carnosine is present in the brain at low millimolar concentrations and exhibits antioxidant, anti-inflammatory, anti-aggregation, and neuroprotective properties. Preclinical studies demonstrate that carnosine inhibits Aβ aggregation, reduces tau hyperphosphorylation, and preserves mitochondrial energy metabolism in neural cells. Clinical RCTs in older adults using BA supplementation have reported cognitive improvements, particularly in those with below-normal baseline function, attributed to elevated brain carnosine.
betaineScientific
Betaine's relevance to the brain is supported by its role in reducing neurotoxic homocysteine, generating SAM for neuronal methylation reactions, and the presence of the betaine-GABA transporter (BGT-1) in brain tissue. In homocystinuria, betaine therapy reduces CNS complications. Preclinical studies in Alzheimer's and Parkinson's disease models show betaine attenuates neuroinflammation and oxidative stress. Direct human CNS RCT data remain limited.
bifidobacterium animalisScientific
B. animalis subsp. lactis HN019 has been proposed to modulate the gut–brain axis via serotonin signaling and SCFA production, and this pathway is invoked to explain its effects on gut motility and bowel function. A proof-of-concept study in healthy women found modulation of brain activities related to mood after consumption of B. animalis-containing fermented milk. Animal data show that BB-12 in synbiotic form reduced anxiety-like behavior in an infant diarrhea mouse model.
bifidobacterium bifidumScientific
B. bifidum BGN4, in combination with B. longum BORI, effectively elevated brain-derived neurotrophic factor (BDNF) expression in aged mice, with evidence of neuroprotection via epigenetic mechanisms. B. bifidum novaBBF7 in a gut-brain axis model reduced neuroinflammation and oxidative stress in human neuronal cells. Reduced Bifidobacterium spp. abundance is consistently associated with neurodegenerative and neuropsychiatric conditions.
bifidobacterium breveScientific
B. breve influences brain function through the gut-brain axis, with preclinical studies showing improvements in synaptic plasticity, BDNF levels, and reduction of Alzheimer's-related behavioral abnormalities. A clinical RCT showed significant improvement in depression and anxiety scores in MDD patients following B. breve CCFM1025 supplementation, with mechanisms linked to tryptophan metabolism and serotonin. Human evidence remains emerging.
bifidobacterium lactisScientific
Through the gut-brain axis, B. lactis strains influence brain function via neurotransmitter precursor modulation (serotonin, GABA), reduction of neuroinflammatory cytokines (IL-1β, TNF-α), and HPA-axis modulation. Multi-strain probiotic formulations containing B. lactis have shown improvements in Depression Anxiety and Stress Scale scores in human clinical trials.
bifidobacterium longumScientific
B. longum 1714 has shown measurable effects on brain activity in human adults, altering EEG patterns at rest and during social stress. An RCT in healthy older adults demonstrated significant improvement across multiple cognitive domains with B. longum BB68S. Preclinical work shows B. longum reduces amyloid burden, restores BDNF, and improves memory in Alzheimer's mouse models.
bilobalideScientific
Bilobalide is one of the two main classes of terpene lactones in Ginkgo biloba extract (alongside ginkgolides), and a primary contributor to its neuroprotective effects. It reduces mitochondrial dysfunction, inhibits apoptosis, and protects against ischemic neuronal damage. Ginkgo biloba extracts standardized to include bilobalide are clinically used for cognitive impairment and dementia in Europe.
biota seedScientific
Biota seed extract has been studied in Alzheimer's disease brain models (5xFAD mice and C. elegans) showing inhibition of amyloid-beta aggregation and improved cognitive outcomes. MAO inhibitor activity restoring brain monoamine neurotransmitters has also been demonstrated preclinically. The herb has historically been used to 'benefit intelligence' in TCM.
black cohoshScientific
Black cohosh has demonstrated direct engagement with brain receptor systems. PET neuroimaging in clinical subjects documented selective changes in μ-opioid receptor availability across multiple brain regions following 12 weeks of supplementation. Serotonergic activity in the hypothalamus is also mechanistically established.
black cuminScientific
Human clinical trials show N. sativa improves memory, attention, cognition, mood, and reduces anxiety. Reviews document neuroprotective evidence for depression, anxiety, neurodegeneration, and cognitive aging. TQ inhibits acetylcholinesterase, prevents hippocampal cell loss, and modulates multiple neurotransmitter systems.
black pepperScientific
Piperine crosses the blood-brain barrier, inhibits MAO-B to preserve dopamine and serotonin, protects neurons against Alzheimer's and Parkinson's toxins, and demonstrates cognitive-enhancing effects in animal dementia models. A comprehensive 2023 Aging and Disease review systematically documents these neuroprotective properties.
black spruceScientific
Picea mariana essential oil has been tested in rodent brain models for depression (2024) and sleep/insomnia (2023), with documented effects on serotonin receptors, GABA-A receptors, BDNF, and CRF protein expression. These are the only published studies directly examining black spruce effects on brain neurochemistry.
black teaScientific
Black tea's caffeine and L-theanine improve multiple brain functions including alertness, attention, focus, and stress resilience in clinical trials. Theaflavins also demonstrate preclinical neuroprotective properties against oxidative damage. The gut-brain axis may mediate additional cognitive-aging benefits via microbiome modulation.
blackberryScientific
Blackberry phenolics exert neuroprotective effects on brain cells by reducing oxidative stress, modulating glutathione, suppressing neuroinflammation, and inhibiting apoptotic pathways. Human longitudinal data associate berry consumption with slowed cognitive decline and better long-term cognitive function. Blackberry polyphenols target multiple brain aging mechanisms including Aβ aggregation and tau pathology.
blueberryScientific
Multiple human RCTs using fMRI, neuropsychological batteries, and cerebral perfusion measures confirm that blueberry supplementation improves brain function, perfusion, and activation in older adults. Evidence spans memory, processing speed, executive function, and neuroplasticity endpoints.
boronScientific
The brain is a primary target organ for boron's biological actions. Human EEG studies confirm boron modulates brain electrical activity; cognitive performance is impaired under boron deprivation; and boron is proposed to influence neurotransmitter availability and membrane function. Lower plasma boron correlates with worse Alzheimer's disease outcomes in observational data.
boswelliaScientific
Pilot RCTs in TBI, multiple sclerosis, and aging populations show Boswellia improves cognitive outcomes, BDNF levels, and neurorecovery. Mechanistically, AKBA reduces neuroinflammation and activates Nrf2-mediated antioxidant defenses in brain tissue, with preclinical evidence for hippocampal dendritic growth and spatial memory improvement.
bovine liverScientific
Bovine liver provides choline (acetylcholine and phosphatidylcholine precursor), B12 (myelin integrity), folate and B6 (neurotransmitter synthesis and homocysteine reduction), copper (neuroenzymatic function), niacin (NAD+), and CoQ10 (neuronal bioenergetics). These collectively support structural brain health, neurotransmission, and protection against neurodegeneration.
broccoliScientific
Sulforaphane crosses the blood-brain barrier, activates Nrf2 in neural tissue, reduces neuroinflammation, and supports mitochondrial function. A comprehensive 2025 review of 84 sulforaphane clinical trials identified neuroprotective effects as documented outcomes. Clinical trials in schizophrenia and autism spectrum disorder have also used sulforaphane.
butyrate triglycerideScientific
Butyrate crosses the blood-brain barrier and modulates BDNF expression, neuroinflammation, and neurotransmitter synthesis. A ButyraGen (tributyrin-containing) clinical study reported improvements in mood and anxiety with proposed direct brain modulation. Preclinical evidence shows butyrate counteracts neurodegeneration-associated changes. The tributyrin-specific human brain-outcome RCT is ongoing.
butyric acidScientific
Butyrate crosses the blood-brain barrier and exerts direct neuroprotective effects including HDAC inhibition, BDNF upregulation, suppression of neuroinflammation, and maintenance of blood-brain barrier integrity. Evidence is strong in preclinical models with emerging human data.
caesalpinia cristaScientific
C. crista leaf and seed extracts have shown direct relevance to brain function: anti-amyloidogenic activity inhibiting Aβ aggregation (Neuroscience Letters, 2010), nootropic activity in scopolamine amnesia models, anxiolytic activity in EPM/staircase models, and anticonvulsant activity across multiple seizure models.
caffeineScientific
Caffeine is the most widely consumed psychoactive substance, acting as an adenosine receptor antagonist in the brain to increase alertness, attention, and cognitive processing speed. Systematic reviews and meta-analyses confirm acute improvements in sustained attention, reaction time, and working memory. Regular consumption has also been epidemiologically associated with reduced risk of cognitive decline and neurodegenerative diseases.
calamari oilScientific
DHA is the predominant structural omega-3 in the brain, accounting for the majority of omega-3 fatty acids in neuronal membranes. Calamari oil is particularly relevant as a high-DHA source. Clinical evidence supports DHA's role in cognitive function, memory, mood, and neuroprotection across the lifespan.
california poppyScientific
California poppy alkaloids have well-characterized interactions with multiple brain receptor systems, established through in vitro electrophysiology and animal studies. GABA-A receptor modulation by (S)-reticuline, serotonin receptor binding, MAO inhibition, and dopamine β-hydroxylase inhibition collectively document activity across major brain neurotransmitter circuits. Human clinical evidence (Hanus et al. 2004 RCT) confirms CNS-active effects in vivo.
caprylic acidScientific
The brain is the primary beneficiary of caprylic acid's ketogenic properties. Ketones derived from C8 cross the blood-brain barrier proportionally to plasma levels and substitute for glucose in states of cerebral energy deficit. Human studies in Alzheimer's disease and aging demonstrate cognitive improvements. C8 is the most ketogenic MCT in humans.
capsanthinScientific
Capsanthin demonstrated neuroprotective effects in glutamate-stressed neuron-like cells by preserving ATP, reducing ROS and inflammatory cytokines, and suppressing apoptotic gene expression. Blood-brain barrier permeability is acknowledged as a pharmacokinetic limitation for in vivo brain effects.
caroteneScientific
Observational evidence from the MacArthur Studies associates higher serum beta-carotene with reduced risk of cognitive decline, particularly in APOE ε4 carriers. Serum carotenoids inversely correlate with pro-inflammatory cytokines implicated in neuroinflammation. Breast milk beta-carotene is associated with infant cognitive development. Preclinical evidence suggests beta-carotene mitigates neuronal oxidative stress and cellular senescence.
caryophylleneScientific
BCP exerts neuroprotection in brain tissue against Alzheimer's, Parkinson's, ischemia, neuroinflammation, and cognitive decline models via CB2 receptor activation, Nrf2/NQO1 antioxidant defense, and microglial modulation. Human microglial cell data are available.
cassia barkScientific
A clinical study documented activation of the olfactory cortex of the brain with cinnamon/cassia. Multiple 2021–2025 animal studies demonstrate C. cassia's neuroprotective effects, including restoration of blood-brain barrier integrity, reduction of hippocampal neurodegeneration, and BDNF upregulation.
catalaseScientific
Catalase activity is reduced in the brains of patients with neurodegenerative diseases; animal studies with mitochondria-targeted catalase show improved cerebrovascular function and neurovascular coupling. Glycation-induced catalase inactivation in Alzheimer's and Parkinson's disease accelerates neuronal loss and cognitive decline.
catechinsScientific
EGCG crosses the blood-brain barrier and exerts direct neuroprotective, anti-neuroinflammatory, and neuroplasticity-promoting effects in the brain. Human trials confirm improvements in cognitive function, memory, and working memory with catechin supplementation. EGCG reduces Aβ aggregation, neuroinflammation, and oxidative stress in the brain.
cauliflowerScientific
Cauliflower provides choline for acetylcholine synthesis and neuronal phosphatidylcholine maintenance—critical for brain function and memory. Sulforaphane protects brain mitochondria via Nrf2 and inhibits neuroinflammation via NF-κB. Prenatal choline and folate from cauliflower support fetal brain development.
chamomileScientific
Multiple RCTs and systematic reviews demonstrate chamomile reduces anxiety and improves sleep quality via apigenin's partial agonism at the GABA-A benzodiazepine receptor site. A systematic review found 9 of 10 studies concluded chamomile is effective for anxiety reduction. An RCT in GAD patients found 1500mg/day chamomile extract produced a 66.2% reduction in HAM-A anxiety scores (p≤0.001).
cherryScientific
Tart cherry phytochemicals cross the blood-brain barrier, exert anti-neuroinflammatory effects, and have been linked to improved memory, attention, and mental fatigue in RCTs spanning older and middle-aged adults. Sleep-modulating melatonin/tryptophan content also supports brain function indirectly.
chinese salvia rootScientific
Danshen has documented neuroprotective effects in the brain, particularly in hippocampal neurons, with evidence spanning Alzheimer's disease, cognitive decline, and cerebral infarction. Multiple mechanisms including Aβ clearance, anti-neuroinflammation, and cerebrovascular protection are relevant. Fufang Danshen is listed in the Chinese Pharmacopoeia for Alzheimer's disease.
chokeberryScientific
Anthocyanins from chokeberry demonstrate neuroprotective activity in animal models of Alzheimer's disease (amyloid-β) and scopolamine-induced cognitive impairment. Aronia fruit juice improves cognitive and locomotor function in aged rats. A human RCT specifically assessed Aronia extract's effects on cognitive performance and mood in middle-aged adults.
cholineScientific
Choline is an essential nutrient critical for the synthesis of acetylcholine (the primary neurotransmitter of learning and memory) and phosphatidylcholine (a major structural component of neuronal membranes). The NIH Office of Dietary Supplements and multiple human studies link choline deficiency to cognitive impairment, and higher dietary choline is associated with better cognitive performance and reduced dementia risk.
chromiumScientific
Chromium has emerging evidence for brain-relevant effects via modulation of neurotransmitter systems (serotonin, dopamine) and brain insulin/glucose metabolism. Animal studies show chromium picolinate increases brain monoamine concentrations and enhances brain glucose transporter expression. A small human RCT in older adults found chromium reduced memory interference and increased activity in brain regions involved in cognitive control.
chrysinScientific
Chrysin exerts neuroprotective effects in the brain through antioxidant, anti-neuroinflammatory, GABAergic, serotonergic, dopaminergic, and neurotrophic mechanisms. Preclinical evidence documents protection in hippocampus, prefrontal cortex, striatum, and substantia nigra across models of anxiety, depression, aging, Parkinson's disease, epilepsy, and ischemia.
cinnamonScientific
Cinnamon extract inhibits amyloid-beta oligomerization, reduces tau aggregation, counteracts diet-induced brain insulin resistance, and improves cognitive behavior in multiple animal models. A 2023 systematic review of 40 studies confirmed cognitive benefits, predominantly in vivo, with emerging clinical evidence.
citicolineScientific
Citicoline (CDP-choline) is a naturally occurring nucleotide considered the most brain-bioavailable form of choline, with clinical trials testing its effects on stroke, dementia, traumatic brain injury, and age-related cognitive decline. It upregulates brain phospholipid synthesis, supports acetylcholine production, and has demonstrated modest neuroprotective benefits in multiple small RCTs. European countries routinely prescribe it for cerebrovascular cognitive disorders.
cocoaScientific
Cocoa flavanols improve cerebral blood flow, oxygenation, and cognitive performance in multiple RCTs. Acute cocoa intake enhances BOLD signal in fMRI and improves cerebral oxygenation measured by fNIRS. Flavanols activate CREB/BDNF pathways in neurons and theobromine shows anti-amyloidogenic properties relevant to Alzheimer's disease.
coconutScientific
MCTs from coconut oil are converted to ketone bodies that cross the blood-brain barrier and serve as alternative fuel for glucose-deprived neurons, directly relevant to Alzheimer's disease and age-related cognitive decline. Multiple RCTs confirm ketone elevation; domain-specific memory improvements have been documented in some trials.
coconut milkScientific
Coconut milk's MCTs generate ketone bodies that serve as alternative brain fuel, particularly relevant in Alzheimer's and age-related cognitive decline. At least 20 human studies of MCT oil (largely derived from coconut) have reported improved memory and cognition in older adults and Alzheimer's patients. Animal studies show MCT reduces amyloid-β plaques, neuroinflammation, and cognitive deficits.
coconut oilScientific
Coconut oil's MCTs elevate plasma ketones that directly fuel the brain as an alternative to glucose, with demonstrated benefits in Alzheimer's disease cognitive outcomes in multiple human trials. A 2024 meta-analysis showed statistically significant cognitive score improvements in AD patients. VCO polyphenols also provide neuroprotection via antioxidant mechanisms.
cod liver oilScientific
DHA constitutes the dominant structural omega-3 fatty acid in brain tissue and is critical for neuronal membrane function, synaptic plasticity, and cognitive performance. Cod liver oil provides DHA, EPA, and vitamin D, all of which support brain structure and function across the lifespan.
coffee fruitScientific
Coffee fruit extract is the best-documented nutritional BDNF elevator, with two published double-blind human clinical studies showing significant plasma BDNF increases at 100 mg. Multiple RCTs in healthy and cognitively impaired adults demonstrate working memory, reaction time, and processing speed improvements. BDNF is central to neurogenesis, synaptic plasticity, and protection against neurodegeneration.
copperScientific
Copper is required for brain development, neurotransmitter synthesis, myelination of white matter, synaptic transmission, and neuronal antioxidant defense. Dysregulation—both excess (linked to Alzheimer's and Parkinson's pathology) and deficiency (causing cognitive impairment and white matter disease)—is associated with neurological disorders.
coptis chinensisScientific
Berberine from Coptis chinensis demonstrates neuroprotective effects in animal models of diabetic cognitive impairment and Alzheimer's disease. TCM texts document use for mental restlessness and 'heat affecting the heart' (mental agitation). The gut-brain axis represents a key mechanistic pathway.
CoQ10 (coenzyme Q10)Scientific
CoQ10 levels in the brain decline with age and are specifically reduced in neurodegenerative disease. It exerts neuroprotective effects against Parkinson's disease, Alzheimer's disease, and ischemia via antioxidant, anti-inflammatory, and mitochondrial-stabilizing mechanisms. Clinical trials in PD and depression comorbid with neurological conditions have been conducted.
cordycepsScientific
Cordyceps militaris protects brain neurons from ischemia-induced death and reduces Alzheimer's-like pathology in rodent models. Cordyceps polypeptides increase cerebral blood flow and improve hippocampal neurotransmitter levels linked to learning and memory. Anti-neuroinflammatory and antioxidant effects reduce lipid peroxidation and excess NO in brain tissue. Some clinical evidence in elderly patients supports improvement of memory and cognitive symptoms.
cowage seedScientific
Cowage seed's L-DOPA and associated phytochemicals demonstrably affect brain neurochemistry in humans. Clinical PD trials show direct motor and neurological outcomes. Preclinical studies show it reduces oxidative stress, neuroinflammation, and ROS in brain tissue and neuronal cell lines.
creatineScientific
Creatine is synthesized in and taken up by the brain, where it plays a critical role in energy homeostasis via the phosphocreatine/creatine kinase system. Oral supplementation measurably increases brain creatine stores detectable by MRS, and this elevation is associated with improvements in memory, processing speed, and cognitive performance across multiple RCTs.
creatine monohydrateScientific
Creatine monohydrate crosses the blood-brain barrier and measurably increases brain creatine concentrations, supporting ATP buffering in this highly energy-demanding organ. Human RCTs demonstrate improvements in memory, processing speed, and attention, with preclinical evidence for neuroprotection and neuroplasticity support.
curcuminScientific
Curcumin, the principal bioactive polyphenol of turmeric (Curcuma longa), has demonstrated neuroprotective properties in both preclinical and clinical studies. A 18-month double-blind RCT (MIND trial, 2018) in 40 older adults found that 90 mg twice daily of a bioavailable curcumin formulation significantly improved memory and attention scores and reduced amyloid and tau burden on PET imaging. Anti-inflammatory and antioxidant mechanisms are primary drivers.
currantScientific
Blackcurrant flavonoids have demonstrated neuroprotective effects in a pilot study, reducing serum TNF-α and preventing microglial swelling in the hippocampus. In vitro and animal studies show acetylcholinesterase inhibition relevant to cognitive protection. Early human research supports mood and cognitive attention benefits.
d-alpha tocopherolScientific
Alpha-tocopherol is the primary lipid-soluble antioxidant in the brain, concentrated in neuronal membranes rich in polyunsaturated fatty acids, and protects against neurodegeneration. Human RCTs show that 2,000 IU/day slows functional decline in Alzheimer's disease, and neuropathological studies link brain α-tocopherol levels to reduced Alzheimer's disease pathology.
D-aspartic acidScientific
D-Asp is found in significant quantities in the brain, where it acts as an endogenous NMDA receptor agonist, modulates hippocampal synaptic plasticity, influences dopamine neuron activity in the substantia nigra, and plays a transient but critical role in brain development. Preclinical studies link altered D-Asp levels to changes in cognition and NMDA receptor expression.
D-riboseScientific
The brain's high ATP demand makes it sensitive to energy depletion, and D-ribose has been studied both preclinically (ischemia models, hippocampal ATP restoration) and clinically (mental clarity outcomes in CFS/FMS trials) for its capacity to support cerebral energy metabolism. Evidence is strongest in preclinical models and indirect in humans.
daidzinScientific
Daidzin crosses into the CNS and demonstrates multiple brain-targeted activities in animal models including GABAergic sedation, anxiolysis, antiepileptic, memory enhancement, and monoaminergic (dopaminergic/serotonergic) modulation. Antioxidant activity also offers potential neuroprotection.
damianaScientific
Preclinical studies confirm damiana crosses the blood-brain barrier and modulates multiple CNS targets. Its constituents inhibit monoamine reuptake, inhibit MAO-B, modulate GABA-A receptors, and reduce glutamatergic signaling in hippocampal tissue. All evidence is preclinical.
DHA (docosahexaenoic acid)Scientific
DHA is the most abundant omega-3 fatty acid in the human brain, comprising approximately 40% of total fatty acids in neuronal tissue. It is essential for membrane fluidity, synaptic transmission, neuroprotection, and anti-neuroinflammatory action. Multiple RCTs and systematic reviews support DHA supplementation for cognitive maintenance, especially in aging populations with low omega-3 status.
DHEA (dehydroepiandrosterone)Scientific
DHEA and DHEAS are classified as neurosteroids synthesized and acting in the brain. They modulate GABA-A, NMDA, and sigma-1 receptors, protect the hippocampus from glucocorticoid-mediated damage, and influence mood, memory, and cognitive performance. DHEA levels in both plasma and CSF are reduced in Alzheimer's disease patients.
DMEA (dimethylethanolamine)Scientific
DMAE is produced endogenously in the brain in small amounts and is classified as a cholinergic brain supplement. Clinical trials using DMAE and its derivative centrophenoxine have examined its effects on brain acetylcholine levels, EEG brain activity, memory, attention, and cognitive decline. Preclinical studies confirmed direct increases in cortical acetylcholine and improvements in spatial memory. EEG studies in humans showed brain electrophysiological changes consistent with increased vigilance. The largest human RCT (n=242) for cognitive outcomes produced null results.
docosahexaenoic acidScientific
DHA is the dominant structural fatty acid in brain gray matter, comprising ~15% of frontal cortex fatty acids and a major fraction of brain membrane phospholipids. It is essential for brain development, neurogenesis, synaptic plasticity, neurotransmitter function, and neuroprotection across the entire lifespan. Clinical RCTs demonstrate DHA's effects on memory, mood, cognition, and brain structure.
dodderScientific
Cuscuta chinensis has documented neurotrophic, neuroprotective, nootropic, and anti-neuroinflammatory activities relevant to brain function. Active constituents promote neural stem cell proliferation, protect against cerebral ischemia, improve memory in scopolamine-induced deficit models, and extend healthspan in C. elegans via neuroprotective compounds. A clinical RCT also supports antidepressant effects.
dogwoodScientific
Cornus officinalis and its iridoid glycosides have been studied in multiple animal brain models including Alzheimer's disease, ischemia, aging, and stress-induced hippocampal damage. Active constituents reduce neuroinflammation, tau pathology, amyloid plaques, and oxidative stress in neurons. Jamaican dogwood acts as a CNS depressant with traditional sedative brain effects.
DPA (docosapentaenoic acid)Scientific
DPA is incorporated into neuronal membranes and is retroconverted to EPA in brain tissue, supporting neural membrane integrity. Preclinical studies demonstrate DPA reduces hippocampal microglial activation and oxidative stress in aged animals, improving learning and synaptic plasticity. DPA-derived SPMs also attenuate neuroinflammation.
EGCG (epigallocatechin gallate)Scientific
EGCG is the most abundant and potent catechin in green tea, with demonstrated neuroprotective, anti-neuroinflammatory, and amyloid-inhibiting properties. Preclinical studies confirm it crosses the blood-brain barrier and inhibits beta-amyloid aggregation. Human studies on green tea consumption and EGCG supplementation show associations with improved cognitive function and reduced risk of cognitive decline.
eggScientific
Eggs supply the brain's most critical dietary nutrients: choline (acetylcholine precursor), DHA (neuronal membrane component), lutein and zeaxanthin (brain carotenoids), and B12. Prospective cohort and RCT data link egg intake to improved cognitive function, verbal memory, and fetal brain maturation scores.
eicosapentaenoic acidScientific
EPA reduces neuroinflammation in the brain by suppressing microglial pro-inflammatory activation, lowering hippocampal apoptosis, and modulating neurotransmitter systems. Clinical evidence supports EPA's role in depression, anxiety, seasonal mood, cognitive preservation, and ADHD—all brain-mediated outcomes.
eleutheroScientific
Eleuthero (Eleutherococcus senticosus), also known as Siberian ginseng, is an adaptogen traditionally used in Russian and Chinese medicine to reduce mental fatigue and improve cognitive performance under stress. Clinical studies show it enhances mental work capacity, reduces fatigue, and improves cognitive function, particularly under conditions of stress or sleep deprivation.
EPA (eicosapentaenoic acid)Scientific
EPA is an essential component of the brain that influences neuroinflammation, mood regulation, and cognitive function. Clinical evidence shows EPA-dominant formulations outperform DHA in treating depression, while epidemiological data link higher EPA blood levels to reduced dementia risk. A 12-week RCT in ADHD youth found 1.2 g/day EPA improved attention and vigilance.
eucommiaScientific
Eucommia constituents cross into the CNS and protect against dopaminergic, cholinergic, and amyloid-related neurodegeneration in preclinical models. Mechanisms include Nrf2-driven antioxidant defense in neurons, AChE inhibition, microglial anti-inflammation, and autophagy regulation. No human brain imaging or cognitive trials exist.
fava beanScientific
Fava beans are a documented dietary source of L-DOPA that crosses the blood-brain barrier and is converted to dopamine by dopaminergic neurons. This has direct and clinically confirmed relevance to brain function, including motor control in Parkinson's disease and dopaminergic tone relevant to mood and cognition.
ferula assafoetidaScientific
Asafoetida exerts neuroprotective, memory-enhancing, and anticonvulsant effects on the brain via AChE inhibition, Nrf2/HO-1 activation, and ferulic acid-mediated GABA modulation. Animal studies and a human RCT support cognitive benefits.
ferulic acidScientific
Ferulic acid crosses the blood-brain barrier and has been studied in Alzheimer's disease, MCI, Parkinson's disease, and depression models. A clinical RCT of FA-containing Feru-guard showed benefits in MCI patients (ages 65–85). FA inhibits Aβ aggregation, activates Nrf2 neuroprotection, suppresses microglial neuroinflammation, and restores brain capillary function.
feverfewScientific
Feverfew has been the subject of multiple RCTs and a 2025 systematic review/meta-analysis for migraine prophylaxis, a condition with clear neurological and cerebrovascular pathophysiology. A meta-analysis of 9 RCTs (n=899) found a significant reduction in migraine attack frequency.
fisetinScientific
Fisetin is a well-characterized brain-active flavonoid, promoting hippocampal LTP, protecting against neurodegeneration, maintaining GSH levels, and reducing neuroinflammation across multiple brain disease models. Preclinical evidence is extensive; one human stroke trial exists.
fish oilScientific
DHA is the dominant structural omega-3 in the brain, comprising ~40% of brain polyunsaturated fatty acids, and is concentrated at synaptic membranes critical for neurotransmission. Fish oil supports brain health across the lifespan—from fetal neurodevelopment through to cognitive aging. EPA modulates neuroinflammation and mood, while DHA provides structural and neuroprotective functions.
flavin mononucleotideScientific
FMN and FAD are essential for neuronal energy metabolism, myelin maintenance, and protection against neuroinflammation and oxidative stress in the brain. FMN depletion in the brain is documented in Alzheimer's disease, and FMN supplementation has ameliorated cognitive dysfunction in preclinical models. Riboflavin transporter deficiency—causing secondary brain FMN/FAD depletion—produces severe neurodegenerative disease in humans.
flaxseedScientific
Flaxseed oil's ALA omega-3 contributes to brain health through neuronal membrane support and anti-inflammatory actions. Animal evidence shows flaxseed oil protects prefrontal cortex neuronal morphology and prevents cognitive deficits. Observational data link dietary ALA intake to reduced cognitive decline.
folic acidScientific
Folic acid, via its active metabolite l-methylfolate, crosses the blood-brain barrier and is essential for SAM-dependent methylation reactions, neurotransmitter synthesis (serotonin, dopamine, norepinephrine), neurogenesis, and DNA repair in neural cells. Low folate status in the brain is associated with depression, dementia, and impaired neurogenesis in the hippocampus. Folate deficiency is also associated with spinal cord syndromes and neuropsychiatric disorders in clinical populations with megaloblastic anemia.
folinic acidScientific
The brain is the primary organ for which folinic acid has specific, well-established clinical indications beyond general folate nutrition. Folinic acid restores CSF 5-MTHF in cerebral folate deficiency syndromes, reversing brain atrophy, leukodystrophy, and seizures. RCTs in ASD document improvements in verbal communication and behavior, and observational evidence links folate status to dementia risk in aging.
FOS (fructooligosaccharides)Scientific
FOS influences brain function via the gut-brain axis: SCFA and microbiome changes affect neuroinflammation, mood, and cognitive function. Animal studies show FOS reduces depression-like behavior, hypothalamic inflammation, and Alzheimer's-related cognitive deficits. Human evidence for direct brain outcomes is currently limited to mechanistic and indirect data.
fu lingScientific
Poria cocos interacts with key brain neurotransmitter systems (GABA, serotonin, dopamine) and protects hippocampal neurons from Aβ-induced and oxidative damage in preclinical models. Human clinical trials confirm effects on sleep (a brain-regulated state). Pachymic acid promotes serotonin release and interacts with GABA-A receptors.
fulvic acidScientific
Fulvic acid inhibits tau protein aggregation (Journal of Alzheimer's Disease, 2011) and promotes disassembly of preformed paired helical filaments in vitro. Its antioxidant and anti-inflammatory properties provide neuroprotective support. A 2025 systematic review found promising evidence for brain aging.
GABA (gamma aminobutyric acid)Scientific
GABA is the primary inhibitory neurotransmitter in the mammalian central nervous system, modulating anxiety, stress, sleep, and neuronal excitability. Oral GABA supplementation has been examined in RCTs for its anxiolytic and relaxation-promoting effects. While blood-brain barrier penetration of exogenous GABA is debated, a 2019 review found evidence for direct and indirect (gut-brain axis) CNS effects at doses of 100–800 mg.
gamma oryzanolScientific
Gamma oryzanol acts on multiple brain regions: it reduces hypothalamic ER stress linked to high-fat diet and metabolic dysfunction, modulates the amygdala monoaminergic system to reduce anxiety and stress responses, and provides neuroprotection against oxidative damage in neuronal cell models.
gamma tocopherolScientific
Post-mortem human brain analyses show that γT brain concentrations are significantly inversely associated with amyloid load and neurofibrillary tangle severity in Alzheimer's disease. Dietary γT intake is inversely associated with incident AD and cognitive decline in prospective cohort studies. Mechanistically, γT neutralizes peroxynitrite in neural tissue and suppresses neuroinflammation.
ganodermaScientific
Preclinical evidence shows Ganoderma lucidum protects against neuroinflammation, prevents memory impairment in Alzheimer's models, and modulates sleep-wake neurotransmission via serotonergic and GABAergic pathways. Human evidence from neurasthenia RCTs and a registered Cochrane review protocol support CNS benefit.
gardeniaScientific
Gardenia jasminoides and geniposide cross the blood-brain barrier and have neuroprotective activity in models of Alzheimer's disease, cerebral ischemia, Parkinson's disease, and depression. Gardenia-based formulas are used clinically in Kampo and TCM for mood and cognitive disorders. The plant's effects on hippocampal metabolomics and HPA axis normalization are documented.
gardenia jasminoidesScientific
Gardenia jasminoides extracts protect brain tissue in models of Alzheimer's disease, Parkinson's disease, cerebral ischemia, and depression through anti-neuroinflammatory, antioxidant, and neuroprotective mechanisms of geniposide and crocin. GJ-4 extract improved cognitive performance in APP/PS1 transgenic AD mice over 12 weeks at 10–50 mg/kg oral dosing.
gastrodiaScientific
Gastrodia elata's primary pharmacological target is the brain. Gastrodin crosses the blood-brain barrier, exerts neuroprotection, modulates multiple neurotransmitter systems, and has been studied in virtually all major neurological conditions including Alzheimer's, Parkinson's, epilepsy, stroke, and depression.
genisteinScientific
Genistein has preclinical evidence for neuroprotection in brain tissue including protection against amyloid-β toxicity, reduction of neuroinflammation, and dopaminergic protection. Clinical evidence from mixed soy isoflavone trials shows modest improvements in cognitive function domains; no RCTs have used isolated genistein for brain-specific outcomes.
gingerScientific
Ginger's bioactive compounds exhibit neuroprotective and cognitive-enhancing properties in preclinical models. Gingerols inhibit amyloid-beta aggregation, acetylcholinesterase, and neuroinflammation relevant to Alzheimer's disease pathology. Human clinical evidence for direct brain/cognitive outcomes is limited but emerging.
ginkgo bilobaScientific
Ginkgo biloba is one of the most extensively studied herbal nootropics, with meta-analyses of RCTs supporting its efficacy in improving cognitive function in patients with dementia and age-related cognitive impairment. Its standardized extract (EGb 761, 120–240 mg/day) improves cerebral blood flow, exhibits antioxidant and anti-PAF activity, and has demonstrated significant cognitive benefits in multiple European regulatory-approved trials.
ginkgo flavone glycosideScientific
Ginkgo flavone glycosides are the flavonoid fraction of standardized Ginkgo biloba extract (EGb 761), standardized to 24%. They provide antioxidant neuroprotection and support cerebral microcirculation. Their contribution to cognitive benefits is established through the extensive EGb 761 clinical trial literature encompassing dementia and age-related cognitive decline.
ginkgoheterosideScientific
Ginkgoheterosides are the flavonoid glycosides (flavone glycosides) of Ginkgo biloba, comprising 24% of standardized EGb 761 extract. They contribute antioxidant and neuroprotective effects in the brain by scavenging free radicals, modulating cerebral blood flow, and supporting cholinergic neurotransmission, consistent with the overall clinical evidence base for standardized Ginkgo extract.
ginkgolidesScientific
Ginkgolides (A, B, C, J) are diterpene lactones unique to Ginkgo biloba that act as potent platelet-activating factor (PAF) antagonists, improving cerebral blood flow and providing neuroprotection. Ginkgolide B has also been studied as a neuroprotective agent in cognitive decline and has demonstrated cerebrovascular and anti-apoptotic activities in multiple preclinical and clinical studies.
ginsengScientific
Ginseng (Panax ginseng) has been used for over 2,000 years in Traditional Chinese Medicine as a 'shen' tonic to support mental performance. Multiple RCTs confirm that standardized Panax ginseng extract (200–400 mg/day) acutely and chronically improves working memory, attention, and mood in healthy young adults and older populations. Ginsenosides are the primary active compounds modulating neurotransmitter and neuroprotective pathways.
ginsenosidesScientific
Ginsenosides are the primary bioactive triterpene saponins of Panax ginseng responsible for its cognitive-enhancing, neuroprotective, and adaptogenic effects. They modulate NMDA receptors, inhibit acetylcholinesterase, upregulate BDNF and NGF, and reduce neuroinflammation. Multiple RCTs of ginsenoside-standardized Panax ginseng extract confirm improvements in working memory, attention, and mood.
GLA (gamma linolenic acid)Scientific
GLA and its metabolite DGLA are incorporated into brain cell membrane phospholipids, influencing membrane fluidity and neurotransmitter receptor function. Clinical research on GLA for ADHD (a neurodevelopmental condition) is preliminary; omega-3/GLA combinations have been investigated in RCTs for ADHD with mixed results. Neuroinflammatory modulation by GLA is mechanistically relevant to brain health.
glehnia littoralisScientific
Animal studies confirm G. littoralis extract promotes hippocampal neurogenesis, protects against ischemic neuronal injury, and reverses cognitive impairment via BDNF/CREB and Nrf2/HO-1 pathways. The 2019 systematic review identifies neuroprotective properties as established.
glutamic acidScientific
Glutamate is the most abundant excitatory neurotransmitter in the human brain, with critical roles in synaptic plasticity, long-term potentiation, learning, cognition, and memory. Glutamatergic dysfunction in the brain is associated with depression, schizophrenia, bipolar disorder, anxiety, dementia, and neurodegeneration. Both deficient and excessive glutamatergic activity at key receptors produce distinct neuropsychiatric and neurodegenerative pathologies.
glycineScientific
Glycine modulates brain function as an NMDA receptor co-agonist (supporting plasticity and cognition), as the ligand for the newly characterized mGlyR/GPR158 receptor (implicated in depression/anxiety), and as a GSH precursor supporting brain antioxidant defense. GlyNAC RCTs in older adults and aged mice demonstrated correction of brain glutathione deficiency, reduced neuroinflammation, and improved cognitive performance.
glycitinScientific
Soy isoflavones including glycitein have demonstrated neuroprotective effects through antioxidant activity and estrogen receptor-mediated enhancement of neural plasticity and reduction of neuroinflammation. The WISH trial specifically included a cognitive composite score as a secondary endpoint with a preparation containing 3 mg glycitein/day. Isoflavones protect against neurodegenerative diseases by modulating neurotransmitter systems and antioxidant pathways.
goji berryScientific
LBP demonstrates broad neuroprotective activity in the brain, protecting against Alzheimer's disease pathology, stroke-induced damage, radiation-induced neurogenesis loss, and hypoxia-induced hippocampal injury. Human pilot data show improved memory and cognitive outcomes in elderly subjects. Reviews identify the brain as a primary target organ for LBP's protective effects.
gotu kolaScientific
Gotu Kola has well-characterized mechanisms of action on the brain including promotion of neuronal dendrite/axon growth, upregulation of BDNF, inhibition of neuroinflammation, antioxidant neuroprotection, and neurotransmitter modulation. Clinical RCTs support working memory improvement in post-stroke and MCI patients. Traditional use as a brain tonic across Ayurveda and TCM spans millennia.
GPC (glycerophosphocholine)Scientific
Alpha-GPC (L-alpha-glycerylphosphorylcholine) is a highly bioavailable choline precursor that readily crosses the blood-brain barrier. It is the metabolic precursor to both acetylcholine and phosphatidylcholine in neurons. Multiple RCTs in patients with Alzheimer's disease and age-related cognitive decline (1,200 mg/day) show significant improvements in cognitive function, and it is approved as a pharmaceutical in Europe for this indication.
grapeScientific
Human RCTs demonstrate grape extract improves cognitive function in healthy older adults. A 2024 double-blind RCT found 250 mg/day standardized grape extract improved memory, attention, language, and visuospatial abilities in 96 older adults within 14–84 days. Resveratrol penetrates the blood-brain barrier in humans and modulates AD biomarkers. Grape polyphenols inhibit amyloid-β aggregation in vitro.
grape seedScientific
A 12-week double-blind RCT in 111 healthy older adults found 250 mg/day GSE improved attention, language, and both immediate and delayed memory versus placebo. Preclinical studies show GSE promotes hippocampal synaptic transmission, reduces amyloid-beta clustering, and reverses cognitive impairment in seizure models. Human evidence is promising but preliminary.
greek mountain teaScientific
GMT has the strongest scientific evidence base among all body systems studied, with direct human evidence of enhanced prefrontal cerebral blood flow (NIRS-measured), improved cognitive function, reduced anxiety, and neuroprotective effects in older adults. Preclinical models confirm amyloid-β inhibition and BDNF-mediated neuroprotection.
green teaScientific
Green tea (Camellia sinensis) contains L-theanine, caffeine, and EGCG—a synergistic triad with well-documented cognitive-enhancing, neuroprotective, and anti-neuroinflammatory effects. Multiple systematic reviews confirm that regular green tea consumption is associated with improved cognitive function and reduced risk of dementia. The combination of caffeine and L-theanine produces distinct improvements in attention and working memory.
guaranaScientific
Guarana influences brain function through adenosine receptor antagonism, improving alertness, reaction time, and cognitive processing. Human RCTs consistently show improved mental performance and reduced fatigue. Neuroprotective effects including anti-acetylcholinesterase activity and reduced neuronal oxidative stress are demonstrated in animal models. A 2023 meta-analysis confirmed significant response time improvements across 8 RCTs.
hericenonesScientific
Hericenones are aromatic compounds derived from the fruiting body of Lion's Mane mushroom (Hericium erinaceus) that stimulate nerve growth factor (NGF) synthesis in the brain. NGF is critical for neuronal survival, differentiation, and maintenance of cholinergic neurons. Multiple preclinical studies and several clinical RCTs support their role in neuroprotection and cognitive enhancement.
hericium mushroomScientific
Hericium erinaceus (Lion's Mane mushroom) is one of the best-evidenced medicinal mushrooms for brain health, supported by multiple RCTs demonstrating cognitive improvements in mild cognitive impairment and healthy older adults. Its unique bioactives—hericenones and erinacines—stimulate NGF synthesis, promoting neuronal growth, repair, and protection against neurodegeneration.
hesperidinScientific
Hesperidin demonstrates direct protective effects on brain tissue by improving cerebral blood flow, enhancing BDNF, reducing amyloid pathology in Alzheimer's models, protecting dopaminergic neurons in Parkinson's models, and reducing hippocampal neuroinflammation. Limited human RCTs support cognitive and memory improvements.
HMR lignanScientific
HMR and its glucuronide reach brain tissue after oral dosing, confirmed in rat pharmacokinetic studies. In a 6-OHDA rodent Parkinson's model, HMRlignan protected dopaminergic neurons and improved motor performance via anti-neuroinflammatory mechanisms. These are animal-model findings with no human brain-specific RCT data.
hopsScientific
Hops compounds—primarily alpha-acids—modulate GABA-A receptor function, interact with serotonin and melatonin receptors, and reduce core body temperature via hypothalamic melatonin receptor pathways. Clinical studies show improvements in sleep architecture (EEG-measured slow-wave sleep) and mood parameters with hops supplementation.
huperzine AScientific
Huperzine A is a potent, highly selective, and reversible acetylcholinesterase inhibitor derived from Huperzia serrata, used in Chinese folk medicine for dementia and memory loss. A systematic review and meta-analysis of RCTs found significant cognitive improvements in Alzheimer's disease versus placebo on MMSE, HDS, and WMS at 8–16 weeks. It readily crosses the blood-brain barrier and also has neuroprotective effects beyond AChE inhibition.
hydroxycitric acidScientific
HCA modulates brain serotonin pathways, demonstrated in isolated rat brain cortex studies where HCA increased 5-HT release and inhibited its reuptake. Some labeled HCA has been detected in brain tissue in animal studies. This central serotonergic mechanism is the proposed basis for HCA's appetite suppression and putative mood effects.
hydroxymatairesinolScientific
Oral HMR and its glucoside metabolite reach brain tissue at measurable concentrations in rodents. In the 6-OHDA PD rat model, HMR reduced neuroinflammatory markers (TNF-α, iNOS, microglial and astrocyte activation) in striatum and substantia nigra and attenuated motor impairment. The estrogen-like and anti-inflammatory activities of HMR are proposed as the mechanistic basis for brain-relevant effects. Evidence is preclinical only.
idebenoneScientific
Idebenone is a synthetic analogue of Coenzyme Q10 (CoQ10) developed specifically for the brain, with enhanced blood-brain barrier penetration. It has been studied in RCTs for Alzheimer's disease and cognitive impairment, showing modest but statistically significant improvements in cognitive scales. It protects neurons from oxidative stress and supports mitochondrial electron transport, particularly important in hypoxic/ischemic conditions.
indian frankincenseScientific
Boswellia serrata has direct evidence for effects on the brain: a 2025 RCT showed improved BDNF levels and cognitive performance in ageing adults; a TBI RCT showed cognitive benefits; and a systematic review confirmed evidence in radiation-induced cerebral oedema. Animal studies show hippocampal BDNF upregulation and dopaminergic neuroprotection.
indian tinosporaScientific
A human double-blind RCT (Bairy et al., 2004) confirmed improved verbal and logical memory in healthy volunteers at 500 mg/day for 21 days. T. cordifolia is neuroprotective in animal models against hippocampal neurodegeneration, oxidative damage, and neurotoxin-induced injury. It modulates monoamine neurotransmitters including serotonin, dopamine, and norepinephrine.
inositolScientific
Inositol is an osmolyte in brain tissue and a substrate for the PI second messenger system that modulates neurotransmitter receptor signaling. Reduced frontal cortex inositol has been documented in post-mortem brains of suicide victims and bipolar disorder patients. Clinical trials of oral inositol at high doses (12–18 g/day) for depression and panic disorder have yielded mixed but mechanistically supported results.
iodineScientific
The brain is a principal target organ for thyroid hormones, which are synthesised using iodine. Iodine deficiency during gestation and early childhood causes irreversible structural and functional brain abnormalities. In adults, thyroid hormone insufficiency secondary to iodine deficiency impairs cognitive performance, memory, and mood. Population and clinical evidence consistently support this relationship.
ironScientific
Iron is essential for brain metabolism, myelination, neurotransmitter synthesis, and cognitive functioning across the lifespan. Iron deficiency during infancy and early childhood causes lasting neurological deficits. In aging and neurodegenerative disease, excessive regional brain iron accumulation—particularly in the basal ganglia and hippocampus—promotes oxidative stress and is associated with amyloid-beta and tau pathology in Alzheimer's disease, contributing to cognitive decline.
jiaogulanScientific
Jiaogulan gypenosides exert documented protective effects on the brain through antioxidant enzyme induction, anti-neuroinflammatory actions, BDNF upregulation, and cholinesterase inhibition. Preclinical studies cover Alzheimer's-type, Parkinson's, hypoperfusion, and ischemia/reperfusion brain injury models.
jujubeScientific
Jujube has multiple characterized neuroprotective mechanisms: GABA-A/5-HT1A modulation for sedation/anxiolysis, AChE inhibition/ChAT enhancement for memory, Nrf2/ARE activation against oxidative neuronal injury, and anti-neuroinflammatory effects. Preclinical evidence spans insomnia, anxiety, memory, epilepsy, and neurodegeneration. Human evidence is limited but positive for sleep/anxiety.
kaleScientific
Sulforaphane from kale activates Nrf2 in neuronal tissue, upregulating neuroprotective antioxidant enzymes and showing promise in preclinical models of Alzheimer's, Parkinson's, and other neurodegenerative diseases. Kale's carotenoids and antioxidant vitamins are associated with better longitudinal cognitive performance in cohort studies.
kannaScientific
Human neuroimaging (fMRI) and EEG studies have directly demonstrated that kanna exerts measurable effects in the brain, specifically reducing amygdala reactivity, altering frontotemporal EEG spectral power, and decoupling amygdala–hypothalamus connectivity. These findings are from double-blind, placebo-controlled RCTs published in peer-reviewed journals.
kavaScientific
Kavalactones act on multiple brain neurotransmitter systems — primarily GABA-A receptor potentiation, voltage-gated ion channel blockade, norepinephrine reuptake inhibition, and MAO-B inhibition — producing clinically verified anxiolytic and sedative effects supported by RCTs and meta-analyses. Human neuroimaging has also documented kavalactone-induced changes in brain GABA levels.
knotweedScientific
Trans-resveratrol from knotweed crosses the blood-brain barrier, inhibits Aβ plaque formation, reduces tau phosphorylation, upregulates BDNF, and has shown improvements in MMSE and ADAS-cog scores in clinical reviews. Polydatin protects against brain infarction in ischemia-reperfusion models. Resveratrol increases cerebral blood flow via nitric oxide pathways.
krill oilScientific
Krill oil supplies DHA and EPA in phospholipid form for neural membrane maintenance and choline as an acetylcholine precursor. The Konagai 2013 RCT demonstrated enhanced prefrontal cortex hemodynamics and working memory in healthy elderly. Extensive animal studies confirm krill oil reduces Alzheimer's-like pathology, neuroinflammation, and oxidative stress in brain tissue.
kudzuScientific
Puerarin crosses the blood-brain barrier and demonstrates neuroprotective effects in cerebral ischemia, vascular dementia, and neurodegeneration models. It is used clinically in China for cerebrovascular diseases and stroke. Effects include reduced infarct size, improved cognition, and reduced neuronal apoptosis.
L-asparagineScientific
L-asparagine is indispensable for brain development; mutations in asparagine synthetase (ASNS) cause asparagine synthetase deficiency (ASNSD), a severe neurodevelopmental disorder with congenital microcephaly, progressive brain atrophy, epilepsy, and intellectual disability. Brain cells rely on local asparagine synthesis because systemic L-asparagine cannot traverse the blood-brain barrier. Asparagine also feeds the malate-aspartate shuttle, which is the primary redox shuttle supporting neuronal energy metabolism.
l-carnitineScientific
ALC readily crosses the blood-brain barrier and supports brain energy metabolism, cholinergic neurotransmission, and neuroplasticity. Clinical trials show benefits in cognitive decline, dementia, depression, and hepatic encephalopathy. Endogenous ALC is a biomarker for major depressive disorder, and Mendelian randomization data support causal links between ALC levels and neurocognitive outcomes.
L-carnosineScientific
L-carnosine is endogenous to the brain and protects against oxidative, glycative, and inflammatory neuronal damage. Human RCTs in elderly adults show preserved verbal memory and improved brain perfusion with supplementation. Brain carnosine is depleted in neurodegenerative diseases, supporting its role in maintaining brain health.
L-cysteineScientific
L-cysteine/NAC crosses the blood-brain barrier and increases neuronal glutathione, modulates glutamate neurotransmission, and reduces neuroinflammation. Clinical trials have demonstrated benefits as an adjuvant in Alzheimer's disease, depression, bipolar disorder, and schizophrenia. The glutamate-modulating mechanism is particularly well-characterized in the brain.
L-glutathioneScientific
Brain GSH deficiency is a documented feature of aging, Alzheimer's disease, and Parkinson's disease, contributing to neuroinflammation, oxidative damage, and cognitive decline. GlyNAC trials in older adults and animal models have specifically corrected brain GSH deficiency, reversed mitochondrial dysfunction, and improved cognition. The brain's high metabolic rate and relatively low ROS-detoxifying enzyme levels make it particularly GSH-dependent.
L-glycineScientific
Glycine is an obligate NMDA receptor co-agonist in the brain, modulating synaptic plasticity, memory, and higher cognitive function. Human clinical trials show GlyNAC improves BDNF levels and MoCA cognitive scores in older adults. High-dose glycine clinical trials in schizophrenia demonstrate that increasing brain glycine availability improves cognitive symptoms via NMDA receptor enhancement.
L-histidineScientific
L-histidine is the sole precursor of brain histamine, modulating cognition, arousal, mood, appetite, and anxiety via extensive tuberomammillary nucleus projections. Histidine-derived carnosine is also concentrated in brain tissue, providing antioxidant and neuroprotective functions. Insufficient histidine demonstrably reduces brain histamine and disrupts neurological homeostasis.
L-leucineScientific
The brain rapidly senses circulating leucine levels via hypothalamic neurons expressing leucine-sensing machinery. Leucine modulates appetite, energy balance, and neuronal excitability independently of peripheral hormones. Electrophysiology on human hypothalamic neurons confirmed direct, rapid effects of leucine on neuronal activity through mechanisms distinct from mTOR.
L-methionineScientific
L-methionine directly influences brain biochemistry via SAMe, which methylates neurotransmitter precursors, maintains neuronal membrane phospholipids, and regulates epigenetic expression of mood-related genes. Animal studies show L-methionine raises brain dopamine and noradrenaline levels. SAMe supplementation (derived from methionine) has documented antidepressant efficacy in human clinical trials at 800–1,600 mg/day.
L-ornithineScientific
L-ornithine protects the brain from ammonia toxicity by enabling hepatic ammonia-to-urea conversion, which is critical in hepatic encephalopathy—a syndrome of brain dysfunction caused by liver failure. LOLA meta-analyses confirm significant improvements in neuropsychiatric function in cirrhotic patients. L-ornithine also modulates brain serotonergic and GABA-A receptor activity, and human RCTs show consistent improvements in cognitive-affective mood outcomes.
L-phenylalanineScientific
L-phenylalanine crosses the blood-brain barrier via large neutral amino acid transporters and contributes directly to brain catecholamine and phenylethylamine synthesis. Human depletion studies show that lowering phenylalanine/tyrosine reduces dopaminergic reward signaling in the nucleus accumbens and impairs mood and cognition. Excess phenylalanine (as in PKU) causes profound brain damage, illustrating its critical role in brain function.
L-serineScientific
L-serine is produced endogenously in the brain by astrocytes and is essential for neuronal development, synaptic function, membrane integrity, and neurotransmitter synthesis. Brain-specific L-serine deficiency in humans causes severe encephalopathy corrected by supplementation. L-serine has been investigated in clinical trials for ALS, early Alzheimer's disease, and epileptic encephalopathies with documented effects on CSF serine levels and brain function.
L-theanineScientific
L-Theanine is a unique amino acid found almost exclusively in tea (Camellia sinensis) that modulates alpha brainwaves, promoting relaxed alertness without sedation. Multiple RCTs demonstrate that L-theanine alone or combined with caffeine improves attention, working memory, reaction time, and reduces anxiety. It modulates glutamate and GABA neurotransmission and has been shown to affect brain activity via EEG.
L-threonineScientific
L-Threonine influences brain neurochemistry as a precursor to glycine, which acts as both an inhibitory neurotransmitter and a co-agonist at NMDA glutamate receptors. Human studies have confirmed that oral L-threonine raises CSF glycine levels. Threonine is also the metabolic source of serine, another amino acid with established roles in brain signaling and neurodevelopment.
L-tryptophanScientific
L-Tryptophan is an essential amino acid and the rate-limiting precursor for serotonin and melatonin biosynthesis in the brain. Clinical RCTs confirm that supplemental L-tryptophan improves mood, reduces anxiety, and supports sleep quality by increasing central serotonin availability. Acute tryptophan depletion (ATD) studies have consistently demonstrated that lowered brain tryptophan impairs memory, mood, and cognitive function.
l-tyrosineScientific
L-Tyrosine is a conditionally essential amino acid and the direct precursor to the catecholamine neurotransmitters dopamine and norepinephrine. Multiple controlled studies show it mitigates cognitive decline under conditions of acute stress, fatigue, sleep deprivation, and cold exposure by replenishing depleted catecholamines in the prefrontal cortex, thereby maintaining working memory, attention, and executive function.
L-valineScientific
L-Valine crosses the blood-brain barrier via the LAT1 transporter, competing with tryptophan and other large neutral amino acids, thereby modulating brain serotonin levels and central fatigue signaling. In the CNS, BCAAs including valine participate in glutamate and GABA neurotransmitter metabolism and in protein synthesis. BCAA pretreatment has been shown neuroprotective in animal traumatic brain injury models.
lactobacillus caseiScientific
L. casei has preclinical evidence for modulating brain-relevant pathways including BDNF-TrkB signaling, NF-κB activation, serotonin, and HPA axis cortisol responses via the gut-brain axis. A mouse study demonstrated that L. casei supplementation alleviated CUMS-induced depression and anxiety by upregulating hippocampal BDNF and inhibiting neuroinflammatory NF-κB. Human evidence is predominantly indirect, through clinical trials on stress-related outcomes.
lactobacillus paracaseiScientific
L. paracasei CCFM1229 maintained myelin basic protein (Mbp) gene expression and structural CNS stability in depressed mice while reducing xanthine oxidase activity — a marker of neuroinflammation. PS23 reduced corticosterone and increased anti-inflammatory IL-10 in the brain context via the gut-brain axis. Human RCTs show improvements in anxiety and sleep consistent with CNS modulation.
lactobacillus plantarumScientific
Clinical and translational evidence links L. plantarum to brain health outcomes including memory protection in older adults, cognitive impairment mitigation, and neuroinflammation reduction via the gut-brain axis.
lactobacillus rhamnosusScientific
L. rhamnosus GG modulates brain function via the gut-brain axis, with documented effects on BDNF levels, GABA receptor expression, HPA axis stress response, and cognitive function in animal models. Human RCT evidence from the Slykerman et al. 2017 trial demonstrates clinically meaningful brain effects (depression and anxiety reduction) with L. rhamnosus HN001.
lavenderScientific
Lavender exerts well-documented effects on the brain through multiple mechanisms: anxiolytic, antidepressant, sedative, anticonvulsive, and neuroprotective actions are supported by both clinical RCTs and animal models. Silexan (oral lavender oil) modulates voltage-gated calcium channels, serotonin transporters, and 5-HT1A receptors in the human brain, confirmed by PET imaging.
lecithinScientific
Lecithin supplies choline for brain acetylcholine synthesis, and phosphatidylcholine is a critical structural component of neuronal membranes. Clinical trials have investigated lecithin for dementia, Alzheimer's disease, and cognitive decline, with mixed results. A 2025 RCT in older adults showed protective effects on cognitive function.
lemon balmScientific
Lemon balm has extensive clinical evidence for CNS effects: RCTs confirm anxiolytic, sedative, mood-improving, and cognitive effects. Mechanisms involve GABA-T inhibition, acetylcholine receptor binding (nicotinic and muscarinic), MAO-A inhibition, and antioxidant neuroprotection. These effects are supported by multiple human trials and recognised in the European Pharmacopoeia, British Herbal Pharmacopoeia, and EMA monograph.
lignansScientific
Lignans demonstrate neuroprotective potential through antioxidant action, anti-inflammatory NF-κB inhibition, and phytoestrogenic effects at brain ERβ receptors. Dietary lignan intake has been observationally associated with better cognitive performance in postmenopausal women. Oxidative stress amelioration in the brain by lignans has been documented in preclinical research.
limoneneScientific
Limonene demonstrates neuroprotective, antidepressant-like, anxiolytic, and cognitive-enhancing properties in preclinical brain models. It modulates monoamine neurotransmitter systems, reduces neuroinflammation in hippocampal tissue, and counteracts amyloid-beta neurotoxicity in cortical neurons. Improvements in learning and memory are documented in animal models of chronic stress.
lion's maneScientific
Lion's Mane (Hericium erinaceus) is a medicinal mushroom with growing clinical evidence for cognitive enhancement and neuroprotection, driven by its bioactive hericenones and erinacines that stimulate nerve growth factor (NGF) synthesis. A landmark 2009 RCT showed significant cognitive improvements in older adults with mild cognitive impairment at 3,000 mg/day for 16 weeks.
lithium orotateScientific
Lithium orotate has documented effects on multiple brain structures and processes, including hippocampal neurogenesis, gray matter volume preservation, prefrontal cortex protection, and reversal of Alzheimer's-like brain pathology in mouse models. A 2025 Nature study specifically identified brain lithium deficiency as an early event in Alzheimer's pathogenesis, with lithium orotate restoring brain function.
lobeliaScientific
Lobeline modulates dopaminergic and noradrenergic neurotransmission in the brain via VMAT2 inhibition and nicotinic receptor interaction. In animal models it increases dopamine and norepinephrine release in limbic regions. The only human brain-function study—a proof-of-concept ADHD trial (n=9)—found modest working memory improvement.
lotus seedScientific
Lotus seed neferine and proanthocyanidins protect the brain from neuroinflammation, amnesic insults, and seizure-induced hippocampal injury in animal models. AChE, BChE, and BACE-1 inhibition by lotus seed extracts is documented with relevance to Alzheimer's disease. No human brain studies exist.
luteinScientific
Lutein is the most concentrated carotenoid in human brain tissue and has been linked to preserved brain structure and function in aging. RCTs show supplementation modifies fMRI-measured brain activation, resting-state connectivity, and gray matter volumes in older adults. Population-based studies confirm that higher serum lutein is associated with greater crystallized intelligence and better performance across multiple cognitive domains, mediated by parahippocampal cortex gray matter.
luteolinScientific
Luteolin's most extensively studied organ target is the brain, with documented effects on neuroinflammation, microglial activation, neurodegeneration, memory, mood, and cognition across numerous preclinical models and some human evidence from combination-product studies.
lycheeScientific
Lychee seed polyphenols and saponins directly affect the brain in rodent studies: they reduce hippocampal Aβ, AGEs, and Tau accumulation, suppress Aβ-induced neuroinflammation, prevent neuronal apoptosis, and improve spatial memory. Proposed mechanisms include improvement of insulin signaling in the brain and PKC pathway activation for neuronal resilience. All evidence is preclinical.
lycopeneScientific
Lycopene crosses the blood-brain barrier and accumulates in brain tissue, where it exerts antioxidant, anti-inflammatory, and neuroprotective effects. Multiple preclinical studies demonstrate mitigation of age-related cognitive decline, and a human epidemiological review (10 studies) found three of four studies showing positive associations between lycopene and maintained cognition in older adults.
macaScientific
Animal and limited human data indicate maca supports brain function through neuroprotective antioxidant effects, improvement of mitochondrial activity in the cortex, modulation of cholinergic signaling, and reduction of anxiety and depression scores in RCTs. Most human evidence remains preliminary.
macadamiaScientific
Macadamia nuts supply tocotrienols and MUFAs that support brain health through neuroprotection and anti-inflammatory mechanisms. Epidemiological evidence links tocotrienol levels to reduced cognitive impairment risk. Oleic acid and tocotrienols in macadamia nuts protect neuronal membranes from oxidative stress and glutamate toxicity in preclinical research.
magnesiumScientific
Magnesium is critical to brain function, serving as a voltage-dependent blocker of NMDA receptors, regulator of synaptic plasticity, and neuroprotective agent against excitotoxicity and neuroinflammation. Brain magnesium levels decline with age and are reduced in patients with Alzheimer's disease. Elevating brain Mg²⁺ via MgT reverses synaptic loss and cognitive deficits in animal models, with supporting human RCT evidence.
magnoliaScientific
Magnolia bark is well-studied for brain effects. Honokiol crosses the blood-brain barrier readily, modulates GABA-A receptors (anxiolytic/sedative), exerts neuroprotective effects against beta-amyloid and ischemia, normalizes BDNF and serotonin in stressed rodent brains, and reduces neuroinflammation. Human data documents cortisol and mood effects; neuroprotective outcomes remain preclinical.
maitake mushroomScientific
Maitake contains ergothioneine, a potent antioxidant that crosses the blood-brain barrier and accumulates in brain tissue, counteracting neuroinflammation and neurotoxin accumulation. A 2026 18-week human RCT found significant improvements in cognitive scores, especially memory, in adults aged 60+.
manganeseScientific
The brain is a primary site of manganese activity through glutamine synthetase in astrocytes, MnSOD in neuronal mitochondria, and modulation of multiple neurotransmitter systems. Excess manganese accumulates preferentially in the basal ganglia, disrupting dopaminergic signaling.
mangosteenScientific
Mangosteen pericarp reduces Alzheimer's pathology markers (Aβ, phospho-tau) and improves cognition in AD mouse models. Xanthones exert anti-neuroinflammatory effects (COX-2 inhibition) in brain tissue. A human 24-week RCT in schizophrenia patients assessed cognitive outcomes with mangosteen pericarp extract. Evidence is predominantly preclinical for brain-specific outcomes.
MCT (medium chain triglycerides)Scientific
The brain is the primary beneficiary organ of MCT-derived ketones. Multiple RCTs have measured direct improvements in brain energy metabolism and cognitive function following MCT supplementation. PET imaging confirms increased brain ketone uptake and altered glucose utilization after MCT ingestion, and fMRI demonstrates changes in neural activation patterns during cognitive tasks.
melatoninScientific
Melatonin is the primary hormone of the pineal gland regulating circadian rhythm and sleep-wake cycles in the brain. Multiple RCTs and meta-analyses confirm its efficacy for sleep onset, jet lag, and circadian rhythm disorders. Beyond sleep, melatonin has demonstrated neuroprotective properties against oxidative stress, neuroinflammation, and beta-amyloid toxicity in preclinical and emerging clinical studies.
methylcobalaminScientific
MeCbl is the predominant active form of vitamin B12 in the brain and is essential for methionine synthase activity, myelin synthesis, neurotransmitter metabolism, and epigenetic regulation via DNA methylation. Brain MeCbl levels decline markedly with age and are significantly reduced in autism and schizophrenia.
milk thistleScientific
Silymarin has demonstrated neuroprotective effects across multiple experimental models including Alzheimer's disease, Parkinson's disease, ischemia, and traumatic brain injury. It suppresses amyloid-β aggregation, reduces neuroinflammation, inhibits glutamate excitotoxicity, and raises BDNF. Emerging human data suggest cognitive benefits in mild cognitive impairment.
mintScientific
Spearmint polyphenol extract has improved working memory and spatial memory in RCTs in adults with age-associated memory impairment. Peppermint aroma has been shown in human studies to improve attention. Menthol interacts with central pain pathways and produces CNS-mediated analgesia.
morusScientific
Morus anthocyanins and polyphenols demonstrate neuroprotective effects on brain tissue in preclinical models, reducing amyloid-β, improving antioxidant enzyme activity in brain tissue, and reducing neuroinflammation. The GABA content of leaves may modulate central nervous system excitability.
muira puamaScientific
Multiple preclinical studies demonstrate direct, measurable effects of orally administered POEE on brain tissue: AChE inhibition in hippocampus and frontal cortex, antioxidant protection of brain cells, neuroprotection against amyloid-beta in an Alzheimer mouse model, and NGF upregulation. Active compounds cross the blood-brain barrier after oral dosing.
mulberryScientific
Mulberry polyphenols and anthocyanins demonstrate neuroprotective effects in animal models, including reduction of hippocampal neuroinflammation, improved spatial memory, and amyloid-β clearance. The 2025 meta-analysis addressed mulberry's modulation of vascular dementia risk factors. Human brain-specific data are lacking.
myrobalanScientific
TC extract demonstrated neuroprotective effects against ischemia in neuronal cell models, prevented amnesia via cholinergic modulation in animal studies, and improved cognitive function and BDNF in a 2025 human RCT. A 2024 review evaluated TC's specific potential in mild cognitive impairment.
NAC (N-acetyl cysteine)Scientific
NAC exerts direct effects on the brain through glutathione replenishment, glutamate neurotransmission modulation, and neuroinflammation reduction. Controlled clinical trials have demonstrated measurable changes in cerebral metabolism and neurochemistry with NAC, and it has been studied in Alzheimer's disease, multiple sclerosis, schizophrenia, and bipolar disorder.
NADHScientific
NADH (reduced nicotinamide adenine dinucleotide) is the biologically active coenzyme form that drives mitochondrial energy production (ATP synthesis) and supports neurotransmitter biosynthesis (dopamine, norepinephrine) in brain neurons. Clinical trials, particularly in Alzheimer's disease and chronic fatigue syndrome, have shown that stabilized oral NADH (5–10 mg/day) can improve cognitive performance and subjective energy.
naringinScientific
Naringenin (naringin's aglycone) demonstrates neuroprotection in Alzheimer's and Parkinson's brain models, clearing Aβ, protecting dopaminergic neurons, inhibiting acetylcholinesterase, and reducing neuroinflammation. Naringin also shows antidepressant and anxiolytic activity in prefrontal cortex models. All evidence is preclinical; brain bioavailability is a recognized limitation.
nattokinaseScientific
Nattokinase has been studied for effects on the brain through its ability to degrade amyloid-beta fibrils, reduce neuroinflammation, improve cerebral blood flow, and protect the blood-brain barrier. The ICC-PACS RCT (2025) used brain MRI as an outcome measure in patients with cerebrovascular stenosis. Multiple preclinical studies in Alzheimer's and stroke models demonstrate reduced amyloid plaque burden, improved neurogenesis, and restored cognitive function with NK administration.
nicotinamide ribosideScientific
Human phase I RCTs have directly shown that NR raises cerebral NAD+ levels (measured by ³¹P-MRS) and CSF NAD+ metabolites in Parkinson's disease patients, altering cerebral metabolism and correlating with clinical improvement. NR was tested in a 24-week RCT for cognitive endpoints in long-COVID. Preclinical evidence demonstrates NR prevents cortical neuronal degeneration, reduces neuroinflammation, and enhances synaptic plasticity.
NMN (β-nicotinamide mononucleotide)Scientific
NMN is a direct precursor to NAD+ (nicotinamide adenine dinucleotide), a critical coenzyme for mitochondrial energy production and sirtuin activation in brain neurons. NAD+ levels decline with age in the brain, and NMN supplementation has been shown in human RCTs to raise blood NAD+ levels significantly. Emerging human trials suggest cognitive and neuroprotective benefits, consistent with preclinical evidence in brain aging models.
nut grassScientific
C. rotundus demonstrates neuroprotective effects against dopaminergic neuronal damage, inhibits brain Na+/K+-ATPase, and shows cognitive-enhancing (nootropic) effects in animal models. It is described as a nootropic agent in the PubMed 2015 comprehensive review.
oatScientific
Oat β-glucan has been associated with reduced difficulty concentrating and reduced anxiety in an RCT. Gut-brain axis mechanisms involving SCFA production from β-glucan fermentation may support neurological function. Evidence is preliminary and this was a secondary outcome in available trials.
oleic acidScientific
Oleic acid produced endogenously in the brain is an essential regulator of neurogenesis, learning, and memory, as demonstrated in a PNAS-published study from Baylor College of Medicine. Dietary oleic acid intake has been associated with cognitive preservation in elderly Japanese cohorts. OEA, derived from oleic acid, also exerts neuroprotective and anti-neuroinflammatory effects through PPAR-α activation.
oliveScientific
Olive polyphenols, particularly oleocanthal, oleuropein, and hydroxytyrosol, target Alzheimer's and Parkinson's-related pathways in the brain: inhibiting amyloid-beta aggregation, enhancing Aβ clearance across the BBB, reducing neuroinflammation, and activating autophagy. Limited human clinical data in mild cognitive impairment subjects show modulation of Alzheimer's blood biomarkers.
olive oilScientific
EVOO's biophenols cross or modulate the blood-brain barrier, reduce neuroinflammation, inhibit amyloid-beta aggregation, and support synaptic plasticity. A 2022 RCT in MCI patients showed EVOO significantly reduced BBB permeability and enhanced brain connectivity. Mediterranean diet with EVOO is epidemiologically associated with lower risk of dementia.
omega-3 fatty acidsScientific
Omega-3 fatty acids, particularly DHA and EPA, are essential for brain structure and function. DHA constitutes approximately 40% of brain fatty acids, supporting membrane fluidity, synaptic transmission, and anti-neuroinflammatory activity. Multiple RCTs and systematic reviews confirm omega-3 supplementation supports cognitive maintenance in aging and may reduce neurodegenerative disease risk.
omega-6 fatty acidsScientific
Arachidonic acid (AA), an omega-6 PUFA, is a major structural lipid in brain tissue, comprising a substantial proportion of neuronal phospholipids. AA is essential for brain development during fetal and early postnatal life and plays roles in neuroinflammation, synaptic plasticity, and neuroprotection. The omega-6:omega-3 ratio in the brain influences cognitive function; an imbalanced ratio is associated with altered executive function in some cohort studies.
omega-9 fatty acidsScientific
Oleic acid (omega-9) is an essential structural and functional lipid in the brain, comprising a major fraction of membrane phospholipids and myelin. OA promotes neuronal growth, synapse formation, and hippocampal LTP. Reduced brain OA is documented in Alzheimer's disease, and rodent studies show OA reduces amyloidosis and ischemic injury.
orangeScientific
Hesperidin from orange has clinical and pre-clinical evidence supporting improvements in cerebral blood flow, cognitive function, and memory. A 2025 Frontiers in Nutrition review characterised hesperidin as a neuroprotective candidate for brain ageing via antioxidant, anti-inflammatory, and synaptic regulatory mechanisms. Vitamin C from orange is also an essential cofactor for brain neurotransmitter synthesis.
oriental arborvitaeScientific
P. orientalis has documented neuroprotective activity in preclinical studies and one TCM clinical application (Naozhenning granules for traumatic brain injury). Seed extracts modulate monoamine neurotransmitters and MAO activity. Leaf-derived EVs improved cognitive and mood parameters in rodent models. TCM traditional use for neurasthenia, anxiety, and insomnia provides historical context.
palm oilScientific
Palm oil-derived α-tocotrienol is a uniquely potent neuroprotective agent. It protects neurons from glutamate-induced death at nanomolar concentrations via c-Src kinase suppression, independent of antioxidant activity. A landmark 2-year human RCT showed palm TRF attenuated progression of brain white matter lesions, and preclinical evidence supports protection against ischemic stroke and Alzheimer's pathology.
peanutScientific
A 16-week RCT found daily peanut consumption improved cerebral blood flow and verbal memory in older adults. Peanut skins provide resveratrol and polyphenols that support brain vascular health. Dietary niacin and vitamin E from peanuts are prospectively linked to protection against cognitive decline and Alzheimer's disease.
PEP (prolyl endopeptidase)Scientific
PREP is expressed at high levels in human brain tissue, including the hippocampus, and modulates neuropeptide availability critical for cognitive function. Genetic and pharmacological manipulation of PREP in rodents alters hippocampal synaptic structure, long-term potentiation, and spatial memory. PREP activity is altered in human brain tissue from Alzheimer's and Parkinson's patients, and PREP inhibitors entered clinical trials for cognitive indications.
peppermintScientific
Human RCTs show peppermint consumption improves multiple domains of cognitive performance and increases cerebral blood flow in the prefrontal cortex. A 2025 randomized placebo-controlled trial using COMPASS cognitive assessment and Near-Infrared Spectroscopy found peppermint tea improved cognitive performance and cerebrovascular parameters versus placebo. Menthol acts as a nAChR agonist and acetylcholinesterase inhibitor, directly modulating brain cholinergic pathways.
perillaScientific
Perilla seed oil ALA provides precursor substrate for brain DHA, and a human RCT in Japanese seniors demonstrated improved cognitive index scores with daily supplementation. Animal models show perilla protects hippocampal neurons against amyloid-beta, oxidative stress, and vascular dementia-related damage. BDNF upregulation and hippocampal LTP enhancement are confirmed mechanisms.
phosphatidylcholineScientific
Phosphatidylcholine (PC) is the predominant phospholipid in neuronal cell membranes and a major source of choline for acetylcholine synthesis. It is concentrated in the brain and provides neuroprotection via multiple pathways. Clinical evidence from studies on soy-derived phosphatidylcholine shows improvements in memory and attention in older adults, and PC is a central component of approved European dementia treatments.
phosphatidylserineScientific
Phosphatidylserine (PS) is a phospholipid concentrated in the inner leaflet of neuronal cell membranes where it plays key roles in signal transduction, neurotransmitter release, and cell survival. The FDA has qualified health claims recognizing its potential cognitive benefits. Multiple RCTs show modest but significant improvements in memory and cognitive function in older adults with age-related memory decline at 300 mg/day.
phosphorusScientific
The brain relies on phosphorus for membrane phospholipid structure, ATP energy provision, and synaptic signaling. Phosphorus magnetic resonance spectroscopy enables direct in vivo measurement of brain phosphorus metabolites, linking phosphorus status to cognitive and neurological function.
pineScientific
Pycnogenol has been studied in 8 RDP trials for cognitive function across age groups, from children with ADHD to elderly adults with memory challenges. A 2022 RCT in 88 children with ADHD showed significant reduction in hyperactivity and oxidative stress markers. Studies in healthy adults and elderly subjects showed improved memory, focus, and decision-making. The 2024 39-trial review confirmed cognition as a documented benefit domain.
pine barkScientific
RCTs confirm Pycnogenol improves cognitive function, memory, and ADHD symptoms. Animal studies show neuroprotection against ischemic injury, amyloid-beta toxicity, and MPTP-induced neurodegeneration. The 2024 Frontiers review validated cognition across six RDP trials. Cerebrovascular and antioxidant mechanisms are central.
polygalaScientific
P. tenuifolia is pharmacologically classified as a cerebrotonic in TCM and Kampo. Preclinical evidence across dozens of peer-reviewed studies documents neuroplasticity promotion, anti-neurodegeneration, memory enhancement, and brain-protective antioxidant/anti-inflammatory effects. A small human trial demonstrated improved spatial and verbal memory.
polygala rootScientific
The brain is the primary target organ of Polygala root's documented pharmacological effects, with human clinical trials demonstrating cognitive enhancement in elderly subjects and multiple preclinical studies confirming neuroprotective, neuroregenerative, and neurotrophic effects in brain tissue.
pomegranateScientific
A human pilot RCT (28 older adults) found pomegranate juice improved verbal/visual memory and fMRI brain activation. Animal models demonstrate reduction of amyloid-beta plaques and cognitive deficits in Alzheimer's models. A 2022 Frontiers in Aging Neuroscience review documents pomegranate's neuroprotective potential for neurological aging disorders.
pomeloScientific
Naringenin from pomelo activates Nrf2, SIRT1, and PI3K/Akt neuroprotective pathways, supports BDNF and NGF neurotrophic factors, and mitigates hippocampal oxidative stress. Naringin prevents cognitive dysfunction in aging rats via TLR4/NF-κB pathway inhibition. A 2025 PMC review concluded naringenin targets multiple hallmarks of brain aging.
poppyScientific
The brain is the central target organ for poppy's opioid alkaloids, with μ-opioid receptors densely distributed in pain-modulating brain regions (periaqueductal gray, thalamus, limbic system). California poppy alkaloids act on GABA-A receptors in the brain to produce anxiolytic and sedative effects.
pregnenoloneScientific
Pregnenolone is synthesized and acts directly within the brain as a neurosteroid, influencing mood, memory, cognition, neuroprotection, myelination, and neuroinflammation. It is the precursor to all brain-synthesized neurosteroids and modulates multiple neurotransmitter receptor systems critical to brain function.
progesteroneScientific
Progesterone is synthesized de novo in the brain (neurosteroid), acts via progesterone receptors in neurons and glia, and is metabolized locally to allopregnanolone. It modulates cognition, mood, sleep, anxiety, and neuroprotection. A 2018 Stanford study linked progesterone to verbal memory and global cognition in postmenopausal women.
propionic acidScientific
Propionate crosses the blood-brain barrier and has documented effects on brain function, including modulation of neuroinflammation, hypothalamic food reward circuits, and microglial activation. Human neuroimaging studies show altered brain responses to high-energy foods following colonic propionate delivery. In neuroinflammatory disease contexts, propionate supplementation has been associated with reduced neuroinflammation and clinical neurological improvement.
pyrroloquinoline disodium saltScientific
Pyrroloquinoline disodium salt is the commercially available and water-soluble disodium form of PQQ (pyrroloquinoline quinone), the form used in most human clinical trials on cognitive function. It shares PQQ's mitochondrial-biogenesis-promoting and neuroprotective mechanisms and demonstrated cognitive improvements at 20 mg/day in double-blind human RCTs.
pyrroloquinoline quinoneScientific
Pyrroloquinoline quinone (PQQ) is a redox cofactor with potent mitochondrial-protective and neuroprotective properties. Human RCTs show PQQ supplementation (20 mg/day) improves memory, attention, and cognitive function, particularly in older adults, likely by promoting mitochondrial biogenesis via PGC-1α and reducing neuroinflammation.
quercetinScientific
Quercetin has been extensively studied in preclinical brain models for Alzheimer's and Parkinson's disease, demonstrating inhibition of amyloid-beta aggregation, tau hyperphosphorylation, and mitochondrial dysfunction in neuronal cell lines and animal models. Human ex vivo and cell line evidence confirms mechanistic neuroprotective actions, though controlled human brain-outcome RCTs remain sparse. Higher dietary flavonol intake has been epidemiologically associated with lower dementia incidence.
rehmanniaScientific
Rehmannia's brain-relevant actions include protection against AD, Parkinson's, ischemia, and depression via catalpol and oligosaccharide mechanisms. Catalpol reduces amyloid-beta toxicity, upregulates antioxidant defences, and inhibits neuronal apoptosis in multiple experimental brain models. A 2025 PMC study identified specific Rehmannia compounds targeting NF-κB and autophagy pathways in AD brain pathology.
rehmannia glutinosaScientific
Rehmannia's bioactive compound catalpol crosses the blood-brain barrier, modulates hippocampal neuroplasticity (GAP-43, BDNF, PKC, PSD-95), protects against amyloid-beta pathology, and promotes GDNF expression in astroglia. It is one of the most frequently cited TCM herbs for memory and dementia formulas.
reishi mushroomScientific
Reishi acts on the brain through GABAergic sedative-adjacent modulation, BDNF upregulation in the prefrontal cortex, anti-neuroinflammation, monoamine restoration (serotonin, norepinephrine), and neuroprotective antioxidant effects. Human clinical evidence includes sleep RCTs, stress/anxiety RCTs, and a small cognitive RCT in breast cancer patients. MSKCC confirms anxiolytic and fatigue-improving effects in clinical studies.
reloraScientific
Relora's primary active compounds (honokiol, magnolol, berberine) directly act on brain receptor systems. Honokiol and magnolol modulate GABA-A receptors in hippocampal neurons and bind to the benzodiazepine site on neurons, affecting sleep and anxiety. Both compounds are highly lipophilic and efficiently cross the blood-brain barrier. Berberine modulates dopaminergic and serotoninergic systems within the brain.
resveratrolScientific
Resveratrol is a polyphenol stilbene found in grapes, red wine, and berries with demonstrated neuroprotective properties. Human RCTs show it improves cerebrovascular function and cognitive performance in older adults. It activates SIRT1, which is neuroprotective, and reduces neuroinflammation and beta-amyloid burden in preclinical models. A 2014 RCT in 119 older adults found improved memory performance with 200 mg/day.
rhodiolaScientific
Rhodiola rosea is an adaptogenic herb with multiple double-blind RCTs demonstrating reduction in mental fatigue, improved cognitive performance, and reduction of stress-induced impairment. A 2012 systematic review (EMA assessment) concluded there is well-established use for temporary relief of mental fatigue. Active compounds salidroside and rosavins modulate monoamine neurotransmitters and the HPA axis.
robusta coffeeScientific
Robusta coffee directly affects brain function through caffeine-mediated adenosine receptor blockade, improving alertness, attention, memory, and mood. Epidemiological data link coffee consumption with reduced brain amyloid pathology and lower risk of dementia and Alzheimer's disease. A human study using a battery of cognitive tests found coffee robusta specifically improved attention, general cognitive ability, and memory versus arabica.
rosemaryScientific
Human studies show rosemary improves memory, alertness, cognitive speed, and brain activity (EEG) in healthy adults and elderly populations. Carnosic acid penetrates the blood-brain barrier and activates neuroprotective NRF2 pathways. EEG studies confirm altered brain activity patterns after rosemary consumption consistent with improved cognitive performance.
rosmarinic acidScientific
Rosmarinic acid has broad neuroprotective effects on the brain including Aβ aggregation inhibition, dopaminergic neuron protection, BDNF upregulation, HPA-axis modulation, neuroinflammation suppression, and GABA transaminase inhibition. Human RCTs have documented brain-mediated effects on mood, anxiety, cognition, and sleep using RA-standardized preparations.
royal jellyScientific
RJ promotes hippocampal neurogenesis, reduces amyloid burden, modulates neurotransmitters, and protects against age-related cognitive decline in multiple animal models. Mechanisms include BDNF/NGF induction, anti-neuroinflammation, and estrogen receptor-mediated synaptogenesis. Human trial evidence is limited to one confounded combination-product study.
rutinScientific
Rutin and its metabolites cross the blood-brain barrier, providing direct neuroprotection. Evidence across Alzheimer's, Parkinson's, and vascular dementia models shows preserved cognitive function, reduced amyloid processing, improved hippocampal neurogenesis, and restoration of brain redox balance.
safflowerScientific
Safflower flavonoids and Safflower Yellow (SY) compounds demonstrate neuroprotective effects across multiple preclinical models. HSYA and Safflower Yellow B (SYB) reduce cerebral infarct area, improve neurological deficit scores, and attenuate oxidative stress and inflammation in ischemia-reperfusion rat models. A retrospective clinical study of 160 acute ischemic stroke patients found safflower yellow pigment improved neurological function and reduced cerebral ischemic area. Safflower flavonoid extract also shows protective effects in Parkinson's disease animal models.
saffronScientific
Saffron (Crocus sativus) has strong and growing clinical evidence for brain health, with RCTs demonstrating antidepressant effects equivalent to SSRIs and cognitive benefits comparable to donepezil and memantine in Alzheimer's disease. Meta-analyses confirm its efficacy for depression and MCI. Active compounds crocin and safranal modulate serotonergic, dopaminergic, and glutamatergic pathways.
sageScientific
Sage directly targets the brain through cholinesterase inhibition, neuroprotection against amyloid-beta toxicity, reduction of neuroinflammation, and antioxidant defense at the blood-brain barrier. Clinical trials in both healthy adults and Alzheimer's patients confirm cognitive enhancements attributable to these central mechanisms.
SAMe (S-adenosyl-L-methionine)Scientific
SAMe is a universal methyl donor produced endogenously from methionine, critical for methylation reactions in the brain including synthesis of neurotransmitters (dopamine, serotonin, norepinephrine, epinephrine) and phospholipids (phosphatidylcholine). Multiple double-blind RCTs confirm SAMe is equivalent to tricyclic antidepressants for depression and superior to placebo, and it improves mood and cognitive function in depressed patients.
sceletiumScientific
The brain is sceletium's primary pharmacological target. Human fMRI studies have directly mapped its acute effects on amygdala circuitry, hypothalamus coupling, and cortical electrical activity. Multiple clinical trials have assessed its effects on neuropsychological performance across mood, anxiety, and cognition domains.
schisandraScientific
Schisandra lignans demonstrate neuroprotective and cognitive-enhancing effects across in vitro, animal, and early human research. Mechanisms include antioxidation, suppression of apoptosis, anti-inflammation, BDNF modulation, and regulation of neurotransmitters. Animal studies show protection against amyloid pathology and dopaminergic neuron damage. Small human studies support improvements in memory and reduced mental fatigue.
schisandrinsScientific
Schisandrins cross the blood-brain barrier and exert neuroprotective, anti-neuroinflammatory, GABA-ergic, and cognitive-enhancing effects in multiple brain models. Preclinical studies document actions in cerebral cortex, hippocampus, and hypothalamus. Small human studies suggest memory and mental fatigue benefits.
seleniumScientific
The brain is a site of exceptionally high selenium concentration and active selenoprotein expression, with the organ maintaining selenium levels through prioritized mechanisms even during systemic deficiency. Selenoproteins regulate antioxidant defense, neuroinflammation, and neurotransmitter pathways in the brain. Observational data link lower brain/CSF selenium species with conversion from mild cognitive impairment to Alzheimer's dementia, and selenium has been studied in RCTs for Alzheimer's disease.
selenomethionineScientific
The brain maintains high selenium concentrations via priority delivery through selenoprotein P, with multiple brain-enriched selenoproteins (GPX4, thioredoxin reductase, selenoprotein P) protecting neurons from oxidative and ferroptotic death. Brain selenium levels decline with age and correlate with cognitive performance in AD patients. Selenomethionine in preclinical Alzheimer's and aging models reduces Aβ, tau hyperphosphorylation, neuroinflammation, and mitochondrial dysfunction while restoring cognitive function.
sesameScientific
Sesamin provides neuroprotection in cell models relevant to Alzheimer's disease and stroke: it scavenges H₂O₂ ROS, reverses BCL-2 decline, limits caspase apoptosis, preserves mitochondrial Sirtuin 3, and reduces neuroinflammation via JNK/p38 modulation. A published PubMed study (PMID 35788665) confirmed sesamin protects against microglial neurotoxicity under high-glucose conditions. Evidence is preclinical but mechanistically specific.
siliconScientific
Silicon may be an essential element in brain tissue, with regional variations in brain silicon independent of dietary intake. Silicon antagonizes aluminum accumulation in brain regions implicated in Alzheimer's disease. A clinical pilot study found silicon-rich water increased urinary aluminum excretion and produced preliminary cognitive improvements in Alzheimer's patients.
silk treeScientific
A. julibrissin has demonstrated neuroprotective, anxiolytic, antidepressant, sedative, and memory-protecting effects in preclinical models. Multiple neurotransmitter systems in the brain are modulated by its constituents. It is extensively used in TCM for brain and spirit-related conditions.
silymarinScientific
Silymarin's neuroprotective effects in the brain are documented across preclinical models of Alzheimer's disease, Parkinson's disease, cerebral ischemia, and cognitive and psychiatric disorders. It reduces neuroinflammation, amyloid-beta deposition, dopaminergic neuronal loss, and oxidative damage in brain tissue. Human clinical brain-specific trials are very limited.
skullcapScientific
Baicalin crosses the blood-brain barrier and demonstrates multiple neuroprotective mechanisms in brain tissue including antioxidant Nrf2 activation, anti-neuroinflammatory effects via SIRT1/HMGB1 and NF-κB, and cognitive protection in Alzheimer's and Parkinson's animal models. Clinical sleep and mood RCTs confirm direct brain function effects.
soyScientific
Soy isoflavones and their metabolite S-equol interact with brain ERβ receptors and vascular mechanisms relevant to cognitive health. Epidemiological data from Asia associate soy intake with lower dementia risk. S-equol reduces arterial stiffness and white matter lesion volume in clinical studies.
soy isoflavonesScientific
Multiple RCTs and a meta-analysis of 16 trials document that soy isoflavones modestly improve overall cognitive function and memory in older adults, mediated via ERβ in the hippocampus and cortex, with additional antioxidant and anti-inflammatory contributions.
soybeanScientific
Soy isoflavones interact with estrogen receptors in the brain and have been studied for neuroprotective and cognitive effects. Phytoestrogens have demonstrated neuroprotective properties in animal studies including reduction of Alzheimer's disease pathology. Epidemiological data from East Asian populations show inverse associations between dietary isoflavone intake and cognitive decline, though RCTs in Western populations have been inconsistent.
spearmint leafScientific
Spearmint extract has demonstrated neuroprotective effects in animal models and statistically significant improvements in working memory, spatial memory, and sustained attention in multiple human RCTs. Rosmarinic acid's inhibition of acetylcholinesterase and amyloid-β aggregation are the leading proposed mechanisms.
spinachScientific
Spinach folate, vitamin K, lutein, beta-carotene, and nitrate are all independently associated with reduced cognitive decline in prospective cohort research explicitly including spinach as a measured food. These nutrients support cerebral blood flow, reduce neuroinflammation, and maintain myelin and sphingolipid metabolism.
spirulinaScientific
A 2021 scoping review of experimental and clinical evidence confirmed spirulina has antioxidant, anti-inflammatory, and neuroprotective mechanisms relevant to brain health. Preliminary clinical studies suggest reductions in mental fatigue and protection of brain vessel endothelium. Use in malnourished children showed improvements in motor, language, and cognitive skills, and spirulina's appetite-regulating effects involve central brain pathways.
SPMs (specialized pro-resolving mediators)Scientific
SPMs are produced in brain tissue and are specifically reduced in Alzheimer's disease. NPD1 (neuroprotectin D1) is named for its brain-specific protective actions. Reduced SPM levels in human hippocampal and entorhinal cortex tissue from AD patients have been documented by multiple research groups.
st. john's wortScientific
SJW exerts well-characterized effects on the central nervous system, inhibiting reuptake of serotonin, dopamine, and norepinephrine, and modulating GABA-A, GABA-B, and glutamate receptors. It demonstrates neuroprotective antioxidant effects and is among the most clinically studied herbal supplements for brain-based conditions.
stigmasterolScientific
Stigmasterol crosses the blood-brain barrier and exerts documented protective effects in the brain: reducing Aβ42 deposition, suppressing neuroinflammation via microglial pathways, improving cognitive performance in animal models, and protecting neurons from oxidative death.
strawberryScientific
Strawberry intake is associated with reduced Alzheimer's dementia risk and less brain amyloid-β and tau pathology in two major cohort studies at Rush University. Pelargonidin, primarily found in strawberries among common fruits, is inversely associated with neurofibrillary tau tangle density. A double-blind RCT found daily strawberry powder improved cognitive processing speed in healthy older adults.
sulforaphaneScientific
Sulforaphane penetrates the blood-brain barrier and is among the most clinically studied dietary neuroprotective agents, with human RCT evidence in schizophrenia, aging, and autism. It upregulates brain glutathione, reduces neuroinflammation, activates BDNF pathways, and supports neurogenesis.
sweet flagScientific
The brain is a primary target organ of A. calamus, with documented AChE inhibitory, neuroprotective, antioxidant, anticonvulsant, and antidepressant effects supported by preclinical studies and early human data. Traditional classification as a brain rejuvenator (medhya rasayana) spans thousands of years.
szechuan lovageScientific
CX has extensive evidence for effects on the brain, including protection against cerebral ischemia, reduction of vascular dementia-related cognitive impairment, neuroprotection against Alzheimer's-related pathology (β-amyloid), and migraine modulation via trigeminal pain pathways. It is clinically used in China for ischemic stroke.
tartarian asterScientific
Preclinical studies show Aster tataricus extract exerts neuroprotective and cognitive-enhancing effects in rodent models. ATE modulates hippocampal cholinergic activity and anti-apoptotic signaling in scopolamine-induced cognitive deficit models and mitigates amyloid-β aggregation in transgenic mouse models. A PTZ-epilepsy study reported significant improvements in cognitive function, dopamine, and 5-HT levels.
taurineScientific
Taurine is a conditionally essential amino acid present in high concentrations in the brain, particularly in the hippocampus and cerebral cortex. It modulates GABA-A and glycine receptors, acts as an inhibitory neuromodulator, and has demonstrated neuroprotective properties against oxidative stress and excitotoxicity. Human studies show taurine improves cognitive function and reduces anxiety in both healthy adults and clinical populations.
terminaliaScientific
T. chebula has both traditional documentation and emerging clinical evidence for brain health. A randomized proof-of-concept clinical trial demonstrated cognitive improvements and BDNF elevation in aging adults with memory complaints. Preclinical evidence supports neuroprotective mechanisms including antioxidant protection, BDNF upregulation, and neuroinflammation reduction.
threonic acidScientific
Threonic acid uniquely penetrates the blood-brain barrier via glucose transporter 3 (GLUT3), directly raising brain Mg²⁺ levels in neurons. This is the defining property that distinguishes magnesium L-threonate from other magnesium salts and underpins all cognitive, memory, and neuroplasticity effects confirmed in human RCTs.
tinospora cordifoliaScientific
T. cordifolia protects hippocampal tissue from oxidative damage, enhances memory and cognition in animal models, shows antidepressant and anxiolytic effects, and is mechanistically linked to Alzheimer's disease targets (BACE1, MAOB) via network pharmacology. In Ayurveda it is a Medhya Rasayana—a brain tonic.
TMG (trimethylglycine)Scientific
The brain is one of the highest-concentration sites for TMG in the body, where it functions as a neuroprotective osmolyte and methylation donor. TMG reduces homocysteine-driven neurotoxicity and neuroinflammation, supports SAMe-dependent neurotransmitter synthesis, and has demonstrated anti-amyloid and anti-inflammatory effects in animal models. Human data show positive associations between plasma betaine and cognitive performance domains in the elderly.
tocotrienolsScientific
Tocotrienols demonstrate neuroprotection in human clinical trials through white matter lesion attenuation, and epidemiological evidence links higher plasma tocotrienol levels to reduced Alzheimer's disease and mild cognitive impairment risk. Alpha-tocotrienol specifically protects neurons via antioxidant-independent mechanisms at nanomolar concentrations.
trans-pterostilbeneScientific
Preclinical evidence shows pterostilbene enhances hippocampal neurogenesis, elevates BDNF, improves memory consolidation in aged and cognitively impaired rats, and protects against neuroinflammation. Its high bioavailability and BBB penetrance are key pharmacological advantages over resveratrol.
tributyrinScientific
Tributyrin supplies butyrate to the brain indirectly via hepatoportal sensing and possibly directly across the blood-brain barrier, exerting neuroprotective and cognitive effects. Animal studies show prevention of hippocampal cognitive decline, modulation of synaptic plasticity, and attenuation of Alzheimer's and Parkinson's-related neuropathology.
turmericScientific
Turmeric (Curcuma longa) contains curcumin as its primary bioactive, with neuroprotective, anti-neuroinflammatory, and potential anti-amyloid properties relevant to brain health. A 2018 RCT (MIND trial) showed bioavailable curcumin (90 mg twice daily) improved memory, attention, and reduced amyloid/tau on PET imaging. Epidemiological evidence from India (high turmeric consumption) is associated with lower Alzheimer's disease prevalence.
ubiquinolScientific
The brain has extremely high metabolic demands and is highly vulnerable to oxidative damage, making ubiquinol relevant to brain health through mitochondrial ATP support, neuronal antioxidant defense, and cerebrovascular protection. Clinical evidence includes migraine RCTs, ME/CFS cognitive fatigue trials, and a dedicated ubiquinol cognitive RCT in healthy elderly adults. CoQ10 decline with aging is associated with increased neurological vulnerability.
uridineScientific
Uridine is a pyrimidine nucleoside and critical precursor for phosphatidylcholine synthesis in neuronal membranes. Combined with DHA and choline (as in the Souvenaid formulation), it has demonstrated improvements in verbal memory and delayed recall in early Alzheimer's disease in the large, multicenter, double-blind SOUVENIR II RCT. Uridine also supports synaptogenesis and BDNF and NGF neurotrophic factor production.
urolithin aScientific
UA demonstrates favorable blood-brain barrier permeability and selective brain tissue distribution. Preclinical evidence shows UA activates neuronal mitophagy, reduces amyloid and tau pathology, suppresses neuroinflammation, and protects dopaminergic neurons. Human data establish UA's systemic effects on aging-related processes relevant to brain health, with dedicated brain-outcome trials underway.
valerian rootScientific
Valerian root (Valeriana officinalis) has established traditional and clinical evidence for CNS-mediated effects, primarily sleep improvement and anxiolysis. Multiple RCTs confirm its ability to reduce sleep latency and improve sleep quality via GABA-A receptor modulation and serotonin receptor interactions. German Commission E and ESCOP have approved it for nervous restlessness and sleep disturbance.
vanillaScientific
Vanillin has demonstrated the ability to cross the blood-brain barrier in animal studies, reduce neuroinflammation, protect dopaminergic neurons, and modulate brain serotonin and dopamine levels. Multiple well-designed preclinical studies support neuroprotective effects relevant to Parkinson's disease, ischemic stroke, and depression models. Human evidence is absent.
velvet beanScientific
L-DOPA from MP seeds crosses the blood-brain barrier and is converted to dopamine in the substantia nigra and striatum, directly addressing the core neuropathology of Parkinson's disease—confirmed in multiple clinical trials. MP also demonstrates neuroprotective activity in hippocampal neurons, GABAergic modulation, and antioxidant defense within brain tissue.
vinpocetineScientific
Vinpocetine is a semi-synthetic compound derived from vincamine (from periwinkle, Vinca minor), with established pharmacological actions in the brain: it increases cerebral blood flow, inhibits PDE1 (raising brain cAMP), blocks voltage-sensitive sodium channels, and is neuroprotective against oxidative and excitotoxic insults. Three clinical studies in older adults showed significantly greater cognitive improvement with vinpocetine versus placebo on global cognitive tests.
vitamin B1Scientific
Vitamin B1 (thiamine) is essential for cerebral glucose metabolism and functions as a cofactor for key enzymes including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase in the brain. Thiamine deficiency causes severe neurological damage (Wernicke-Korsakoff syndrome, beriberi-neuropathy). Supplementation with benfotiamine (fat-soluble form) has shown cognitive benefits in Alzheimer's disease RCTs.
vitamin B12Scientific
Vitamin B12 (cobalamin) is essential for myelin sheath synthesis, neuronal DNA methylation, homocysteine reduction, and nerve conduction. Deficiency causes subacute combined degeneration of the spinal cord and cognitive impairment. Elevated homocysteine (a consequence of B12 deficiency) is a significant independent risk factor for dementia. Supplementation reduces homocysteine and may slow brain atrophy, as demonstrated in RCTs.
vitamin B2Scientific
FAD-dependent mitochondrial energy production is critical for brain function, and riboflavin is actively transported to the brain. Riboflavin modulates the kynurenine pathway, producing neuroactive metabolites. A 2-year prospective cohort study found dietary riboflavin intake improved multi-domain cognitive function in middle-aged and elderly populations.
vitamin B3 (niacin)Scientific
Niacin (vitamin B3) is a precursor to NAD+ and NADP+, critical cofactors for neuronal energy metabolism and sirtuin (SIRT1) activation, which is neuroprotective. Pellagra (niacin deficiency) causes dementia as one of its 'three Ds.' Supplemental niacin and its derivatives (niacinamide, nicotinamide riboside) are being actively studied for neuroprotection in Alzheimer's and Parkinson's disease.
vitamin B3 (niacinamide)Scientific
Niacinamide (nicotinamide, a non-flush form of vitamin B3) is a direct NAD+ precursor with neuroprotective properties, particularly relevant to Alzheimer's disease. A 2020 pilot RCT and multiple preclinical studies show niacinamide reduces tau phosphorylation and restores cognitive function. Active clinical trials are evaluating 1,500 mg/day niacinamide in Alzheimer's based on compelling preclinical evidence.
vitamin B5Scientific
Vitamin B5 (pantothenic acid) is essential for synthesis of coenzyme A (CoA), which is required for acetylcholine synthesis in cholinergic neurons and for fatty acid metabolism critical to myelin formation and neuronal membrane maintenance. Deficiency causes neurological symptoms including paresthesia and sensory neuropathy. It supports cognitive function as a necessary cofactor in brain acetylcholine production.
vitamin B6Scientific
Vitamin B6 (pyridoxine) as pyridoxal-5'-phosphate (PLP) is a cofactor for over 100 brain-relevant enzymatic reactions, including synthesis of serotonin, dopamine, GABA, norepinephrine, and epinephrine. It also reduces neurotoxic homocysteine. B6 deficiency causes seizures (in infants), depression, and cognitive impairment. Combined B6/B12/folate supplementation (VITACOG trial) slowed brain atrophy and cognitive decline in MCI.
vitamin B9 (folate)Scientific
Folate (vitamin B9) is essential for one-carbon metabolism in the brain, including DNA methylation, nucleotide synthesis, and remethylation of homocysteine to methionine. Folate deficiency elevates neurotoxic homocysteine and impairs SAMe production. Low folate is linked to depression, cognitive decline, and neural tube defects. Multiple RCTs confirm folic acid supplementation reduces homocysteine and cognitive impairment risk.
vitamin B9 (methylfolate/5-MTHF)Scientific
5-MTHF (methylfolate) is the biologically active, blood-brain barrier-crossing form of folate that directly participates in neurotransmitter synthesis and homocysteine remethylation in the brain. It bypasses the MTHFR enzyme conversion required for folic acid, making it the preferred form for those with MTHFR polymorphisms (~40% of the population). RCTs confirm cognitive and antidepressant benefits, particularly in MTHFR-polymorphism carriers.
vitamin EScientific
The brain is highly vulnerable to oxidative stress due to its high metabolic rate and lipid-rich composition. Vitamin E accumulates in neural tissue and clinical/epidemiological evidence consistently links higher vitamin E status to lower risk of Alzheimer's disease and slower cognitive decline. Low brain α-tocopherol levels are documented in Alzheimer's disease and APOE ε4 carriers.
wasabiScientific
A human double-blind RCT confirmed that 6-MSITC improved episodic memory in adults aged 60+. ME/CFS trials showed reduced brain fog, improved cognitive processing speed, and enhanced mood. Nrf2-mediated neuroprotection is the primary mechanism, supported by neuronal cell microarray data showing oxidative stress gene modulation as the dominant effect.
waterhyssopScientific
Bacopa monnieri acts directly on the brain through bacoside-mediated mechanisms, confirmed by RCTs showing improvements in memory, attention, processing speed, and mood, and by mechanistic studies showing effects on hippocampal function, cerebral blood flow, and multiple brain neurotransmitter systems.
wheat germScientific
Wheat germ provides folate, vitamin E, B vitamins, spermidine, and omega-3 fatty acids that support brain function, neurotransmitter synthesis, cognitive resilience, and protection against age-related neurodegeneration. Wheat germ extract-derived spermidine has been clinically tested in older adults for cognitive protection. Wheat germ consumption increased BDNF in T2DM patients in an RCT.
withanolidesScientific
Withanolides are the primary steroidal lactone bioactives of Ashwagandha (Withania somnifera) responsible for its adaptogenic, neuroprotective, and cognitive-enhancing properties. They modulate the HPA axis, inhibit acetylcholinesterase, promote BDNF expression, and reduce neuroinflammation. RCTs using withanolide-standardized ashwagandha extracts confirm cognitive improvements in memory, working memory, and executive function.
yerba mateScientific
Yerba mate's caffeine and theobromine drive acute CNS effects including improved alertness, mood, and psychomotor performance. Polyphenol constituents show neuroprotective potential in preclinical models through antioxidant and anti-neuroinflammatory mechanisms. Preliminary human data link habitual consumption to reduced cognitive impairment risk.
yohimbeScientific
Yohimbine exerts direct effects on the brain through central α2-adrenergic receptor blockade, serotonin 5-HT1A agonism, and dopamine D2 receptor antagonism. Central effects include increased alertness, mood shifts toward excitation, potential anxiety, and studied facilitation of fear-extinction memory consolidation. It is used as a pharmacological tool to probe brain noradrenergic function in human research.
zeaxanthinScientific
Lutein and zeaxanthin together constitute 66–77% of total carotenoids in human brain tissue, accumulating in regions critical to memory and executive function. RCTs using fMRI and cognitive testing demonstrate that L+Z supplementation enhances cerebral perfusion and buffers verbal learning decline in older adults. Epidemiological evidence consistently links higher brain/serum xanthophyll levels with better cognitive outcomes.
zincScientific
Zinc is an essential trace mineral present in particularly high concentrations in the brain, especially in the hippocampus and cerebral cortex. It modulates NMDA receptor activity, synaptic plasticity, and neurogenesis. Zinc deficiency impairs cognitive development and function; supplementation improves attention and cognition in deficient populations and has been studied for Alzheimer's disease.
gooseberryTraditional
Amla is a classical Ayurvedic brain tonic (medhya rasayana). Preclinical evidence documents neuroprotective activity, and antioxidant protection of brain cells from oxidative damage has been mechanistically confirmed. Human clinical brain endpoint trials are absent.
passionflowerTraditional
Passionflower (Passiflora incarnata) has a long traditional use in European and North American herbalism as a sedative and anxiolytic for the central nervous system. Commission E and ESCOP have approved passionflower for nervousness and anxiety. Clinical trials confirm anxiolytic effects comparable to low-dose benzodiazepines, mediated by modulation of GABA-A receptors and monoamine neurotransmission.
peonyTraditional
Paeoniflorin and P. lactiflora extract demonstrate multiple preclinical brain-protective effects including anti-amyloidogenic activity, BDNF upregulation, and protection of dopaminergic neurons. Traditional use includes calming the spirit and treating dizziness, with neuroprotective mechanisms increasingly characterized at the molecular level.
pituitary substanceTraditional
Pituitary substance has a documented traditional association with brain and cognitive function support within glandular therapy, as the pituitary is an extension of the brain and produces endorphins and other neuroactive factors. Traditional practitioners recommended it for mental clarity and fatigue. No clinical trial evidence exists for oral supplementation.
triphalaTraditional
Triphala is classified as a 'Medhya Rasayana' (brain-nourishing rejuvenative) in Ayurveda, used to enhance memory and cognitive function. Preclinical evidence demonstrates protection against stress-induced neurological changes and antioxidant protection of neuronal tissue. No human clinical trial has measured cognitive endpoints with Triphala.
wood betonyTraditional
The brain and head are wood betony's most historically prominent organ affinities—it was called 'sovereign remedy for all maladies of the head'. Traditional use encompasses headaches, memory, concentration, brain fog, and nervous system restoration. Cerebral circulatory effects are proposed.

Other Names

Synopsis

Brain

Overview and Definition

Major Structural Components

The Cerebrum

Gray Matter and White Matter

Neurons and Glial Cells

The Cerebellum

The Brainstem

The Limbic System

The Thalamus and Hypothalamus

The Ventricles and Cerebrospinal Fluid

Physiological Functions

Sensory Processing and Motor Control

Energy Metabolism

Higher Cognitive Functions

Neuroendocrine Integration

Assessment of Brain Health

Standard Clinical Tools

Multidimensional Brain Health Indices

Factors Supporting Normal Brain Function

Nutrients Studied to Support the Brain

Omega-3 Polyunsaturated Fatty Acids (EPA, DHA, ALA)

Scientific Evidence

B Vitamins (Folate, B6, B12)

Scientific Evidence

Vitamin D

Scientific Evidence

Choline

Scientific Evidence

Herbs and Natural Ingredients Studied to Support the Brain

Ginkgo biloba

Traditional Use

Scientific Evidence

Bacopa monnieri (Brahmi)

Traditional Use

Scientific Evidence

Lion's Mane Mushroom (Hericium erinaceus)

Traditional Use

Scientific Evidence

Other Studied Nutrients and Phytonutrients

Conditions and Diseases of the Brain

Alzheimer's Disease and Other Dementias

Parkinson's Disease

Epilepsy

Migraine and Headache Disorders

Multiple Sclerosis

Rare Neurological Disorders

Cognitive Impairment and Mild Cognitive Impairment (MCI)

Disruptions in Thalamic Function

References

Natural Remedies

Ingredients

Stay informed. Stay healthy.